WO2018002379A2 - Enzymatic preparation of indigo dyes and in situ dyeing process - Google Patents

Enzymatic preparation of indigo dyes and in situ dyeing process Download PDF

Info

Publication number
WO2018002379A2
WO2018002379A2 PCT/EP2017/066410 EP2017066410W WO2018002379A2 WO 2018002379 A2 WO2018002379 A2 WO 2018002379A2 EP 2017066410 W EP2017066410 W EP 2017066410W WO 2018002379 A2 WO2018002379 A2 WO 2018002379A2
Authority
WO
WIPO (PCT)
Prior art keywords
peroxygenase
indole
identity
seq
variant
Prior art date
Application number
PCT/EP2017/066410
Other languages
French (fr)
Other versions
WO2018002379A3 (en
Inventor
Owik Matthias HEROLD-MAJUMDAR
Morten TOVBORG
Martin Hofrichter
Marzena Poraj-Kobielska
Henrick LUND
Original Assignee
Novozymes A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes A/S filed Critical Novozymes A/S
Publication of WO2018002379A2 publication Critical patent/WO2018002379A2/en
Publication of WO2018002379A3 publication Critical patent/WO2018002379A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B7/00Indigoid dyes
    • C09B7/02Bis-indole indigos
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0071Process features in the making of dyestuff preparations; Dehydrating agents; Dispersing agents; Dustfree compositions
    • C09B67/0083Solutions of dyes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0065Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165Heterorings having nitrogen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/02Oxidoreductases acting on a peroxide as acceptor (1.11) with H2O2 as acceptor, one oxygen atom of which is incorporated into the product (1.11.2)
    • C12Y111/02001Unspecific peroxygenase (1.11.2.1)
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06PDYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
    • D06P1/00General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
    • D06P1/0004General aspects of dyeing
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06PDYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
    • D06P1/00General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
    • D06P1/008Preparing dyes in situ
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06PDYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
    • D06P1/00General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
    • D06P1/22General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using vat dyestuffs including indigo
    • D06P1/228Indigo

Definitions

  • the present invention relates to use of a peroxygenase for preparing indigo dyes and an in situ method for dyeing a textile with indigo dyes.
  • Indigo dye is an organic compound with a distinctive blue color. Historically, indigo was a natural dye extracted from plants, and this process was important economically because blue dyes were once rare. Nearly all indigo dye produced today - several thousand tons each year - is synthetic. Indigo is the blue of blue jeans.
  • indigo The primary use for indigo is as a dye for cotton yarn, which is mainly for the production of denim cloth for blue jeans. On average, a pair of blue jean trousers requires 3 - 12 g of indigo. Small amounts are used for dyeing wool and silk.
  • the dye powder must be reduced to the soluble leuco form using sodium dithionite as reduction agents and alkali (for example, sodium hydroxide).
  • the textile is then dipped into the dyeing bath containing the reduced leuco indigo and subsequently exposed to air to let the indigo oxidize. Since the dye take up is limited, this process is repeated 6 - 8 times in consecutive arranged tanks.
  • the consumption of reduction agent is increasing over each step and waste water containing sulfate is produced.
  • Another possibility is the use of pre-reduced indigo which is reduced at the dye manufacturer and then shipped in inert containers to the dyeing house.
  • the chemistry used for producing indigo is quite harsh and not very environmentally friendly. It comprises the use of high temperature and molten alkali.
  • WO 2014/122109 discloses a method for preparing an indigo dye, comprising contacting an indole with a peroxygenase and a source of hydrogen peroxide.
  • the present invention provides a method for dyeing a textile, comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and a substituted or unsubstituted indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, S0 3 " , alkyl and alkoxy.
  • the present invention provides a method or process for converting a substituted or unsubstituted indole to the corresponding 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/- indole, comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2,3-epoxy-1 /-/- indole or 3-hydroxy-1 /-/-indole may be substituted once or twice in the benzene ring (the aromatic ring) and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, S0 3 " , alkyl and alkoxy.
  • the invention provides a method for preparing a substituted or unsubstituted indigo dye, comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring (the aromatic ring) and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, S0 3 " , alkyl and alkoxy.
  • the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • the amino acid sequence comprises the motif: E-H-D-[G,A]-S-[L,I]-S-R.
  • Peroxygenase means an enzyme exhibiting "unspecific peroxygenase” activity according to EC 1.1 1.2.1 , that catalyzes insertion of an oxygen atom from H2O2 into a variety of substrates, such as nitrobenzodioxole.
  • peroxygenase activity is determined according to the procedure described in M. Poraj- Kobielska, M. Kinne, R. Ullrich, K. Scheibner, M. Hofrichter, "A spectrophotometric assay for the detection of fungal peroxygenases", Analytical Biochemistry (2012), vol. 421 , issue 1 , pp. 327- 329.
  • the peroxygenase of the present invention has at least 20%, preferably at least 40%, more preferably at least 50%, more preferably at least 60%, more preferably at least 70%, more preferably at least 80%, even more preferably at least 90%, most preferably at least 95%, most preferably at least 100%, most preferably at least 120%, and even most preferably at least 150% of the peroxygenase activity of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • Mature polypeptide is defined herein as a polypeptide having peroxygenase activity that is in its final form following translation and any post-translational modifications, such as N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, etc.
  • the mature polypeptide has the amino acid sequence shown in positions 1 to 328 of SEQ ID NO: 1 based on the N-terminal peptide sequencing data (Ullrich et al., 2004, Appl. Env. Microbiol. 70(8): 4575-4581 ), elucidating the start of the mature protein of AaeAPO peroxygenase enzyme.
  • Identity The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter "identity”.
  • the degree of identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends in Genetics 16: 276-277; http://emboss.org), preferably version 5.0.0 or later.
  • the optional parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
  • the output of Needle labeled "longest identity" (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
  • Parent or parent peroxygenase means any polypeptide with peroxygenase activity to which an alteration is made to produce the enzyme variants of the present invention.
  • variant means a polypeptide having peroxygenase activity comprising an alteration, i.e., a substitution, insertion, and/or deletion, at one or more (e.g., several) positions.
  • a substitution means replacement of the amino acid occupying a position with a different amino acid;
  • a deletion means removal of the amino acid occupying a position; and
  • an insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position
  • the variants of the present invention have at least 20%, e.g., at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 100%, at least 120%, or at least 150% of the peroxygenase activity of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • the mature polypeptide disclosed in SEQ ID NO: 19 is used to determine the corresponding amino acid residue in another peroxygenase.
  • the amino acid sequence of another peroxygenase is aligned with the mature polypeptide disclosed in SEQ ID NO: 19, and based on the alignment, the amino acid position number corresponding to any amino acid residue in the mature polypeptide disclosed in SEQ ID NO: 19 is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277), preferably version 5.0.0 or later.
  • the parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
  • Identification of the corresponding amino acid residue in another peroxygenase can be determined by an alignment of multiple polypeptide sequences using several computer programs including, but not limited to, MUSCLE (multiple sequence comparison by log - expectation; version 3.5 or later; Edgar, 2004, Nucleic Acids Research 32: 1792-1797), MAFFT (version 6.857 or later; Katoh and Kuma, 2002, Nucleic Acids Research 30: 3059-3066; Katoh et al., 2005, Nucleic Acids Research 33: 51 1 -518; Katoh and Toh, 2007, Bioinformatics 23: 372-374; Katoh et al., 2009, Methods in Molecular Biology 537: 39-64; Katoh and Toh, 2010, Bioinformatics 26: 1899-1900), and EMBOSS EMMA employing ClustalW (1.83 or later; Thompson et al., 1994, Nucleic Acids Research 22: 4673-4680), using their respective default parameters.
  • MUSCLE multiple sequence comparison
  • proteins of known structure For proteins of known structure, several tools and resources are available for retrieving and generating structural alignments. For example the SCOP superfamilies of proteins have been structurally aligned, and those alignments are accessible and downloadable.
  • Two or more protein structures can be aligned using a variety of algorithms such as the distance alignment matrix (Holm and Sander, 1998, Proteins 33: 88-96) or combinatorial extension (Shindyalov and Bourne, 1998, Protein Engineering 1 1 : 739-747), and implementation of these algorithms can additionally be utilized to query structure databases with a structure of interest in order to discover possible structural homologs (e.g., Holm and Park, 2000, Bioinformatics 16: 566-567).
  • Insertions For an amino acid insertion, the following nomenclature is used: Original amino acid, position, original amino acid, inserted amino acid. Accordingly the insertion of lysine after glycine at position 195 is designated “Gly195Glyl_ys” or “G195GK”. An insertion of multiple amino acids is designated [Original amino acid, position, original amino acid, inserted amino acid #1 , inserted amino acid #2; etc.]. For example, the insertion of lysine and alanine after glycine at position 195 is indicated as "Gly195Glyl_ysAla" or "G195GKA”.
  • the inserted amino acid residue(s) are numbered by the addition of lower case letters to the position number of the amino acid residue preceding the inserted amino acid residue(s).
  • the sequence would thus be:
  • variants comprising multiple alterations are separated by addition marks ("+"), e.g., "Arg170Tyr+Gly195Glu” or “R170Y+G195E” representing a substitution of arginine and glycine at positions 170 and 195 with tyrosine and glutamic acid, respectively.
  • Wild-type peroxygenase means a peroxygenase expressed by a naturally occurring microorganism, such as a bacterium, yeast, or filamentous fungus found in nature.
  • Alkyl in the present context represents a linear or branched hydrocarbon radical having 1 -3 carbon atoms. Representative examples include methyl, ethyl, n-propyl and / ' so-propyl.
  • Alkoxy in the present context represents a radical of the formula -OR, where R is alkyl as defined above. Representative examples include methoxy, ethoxy, n-propoxy and / ' so-propoxy.
  • Textile The term “textiles” used herein is meant to include fibers, yarns, fabrics and garments.
  • Fabric can be constructed from fibers by weaving, knitting or non-woven operations. Weaving and knitting require yarn as the input whereas the non-woven fabric is the result of random bonding of fibers (paper can be thought of as non-woven).
  • the term "fabric" is also intended to include fibers and other types of processed fabrics.
  • the method of the invention may be applied to any textile known in the art (woven, knitted, or non-woven).
  • the process of the present invention may be applied to cellulose-containing or cellulosic textile, such as cotton, viscose, rayon, ramie, linen, lyocell (e.g., Tencel, produced by Courtaulds Fibers), or mixtures thereof, or mixtures of any of these fibers together with synthetic fibres (e.g., polyester, polyamid, nylon) or other natural fibers such as wool and silk., such as viscose/cotton blends, lyocell/cotton blends, viscose/wool blends, lyocell/wool blends, cotton/wool blends; flax (linen), ramie and other fabrics based on cellulose fibers, including all blends of cellulosic fibers with other fibers such as wool, polyamide, acrylic and polyester fibers, e.g., viscose/cotton/pol
  • the present invention provides a method for dyeing a textile, comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and an indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, SO3 " , alkyl and alkoxy.
  • the present invention provides a method or process for converting a substituted or unsubstituted indole to the corresponding 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/- indole, comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2,3-epoxy-1 /-/- indole or 3-hydroxy-1 /-/-indole may be substituted once or twice in the benzene ring (the aromatic ring) and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, S0 3 " , alkyl and alkoxy.
  • the invention provides a method for preparing a substituted or unsubstituted indigo dye, comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring (the aromatic ring) and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3 " , alkyl and alkoxy.
  • Indole (or 1 /-/-indole) and indole derivates can be epoxidized to 2, 3-epoxy-1 /-/-indole (and corresponding derivates) using peroxygenases ("APO/UPO") and hydrogen peroxide.
  • 3-Epoxy-1 /-/-indole further rearranges to 3-hydroxy-1 /-/- indole (may be referred to as indoxyl), which spontaneously is oxidized by oxygen (for example from air) to form indigo.
  • the 1 /-/-indoles may contain 1 or 2, the same or different substituents R, where R may be F, CI, Br, OH, NH 2 , COOH (carboxyl), S0 3 " (sulfonate), alkyl or alkoxy.
  • Non-substituted 1 /-/-indole produces indigo and 3,3-dihydro-1 /-/-indol-2-ones (may be referred to as 2-oxindol or 2-oxindole), while derivatives of indole produce a variety of purple, violet, and red colors. 6,6'-dibromoindigo is also known as tyrian purple.
  • the peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole.
  • the peroxygenase has at least 1 10%, for example, at least 150%, at least 200%, at least 300%, at least 500%, at least 800%, or at least 1000% selectivity for 3-hydroxy-1 /-/-indole, compared with Agrocybe aegerita unspecific peroxygenase (/AaeUPO), when the peroxygenase is used to convert an indole to an indigo dye.
  • Agrocybe aegerita unspecific peroxygenase /AaeUPO
  • the peroxygenase having an increased selectivity for 3-hydroxy- 1 /-/-indole has a decreased selectivity for 2-oxindole.
  • the peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole has about 1 -90%, for example, about 5- 80%, about 10-70%, or about 15-60% selectivity for 2-oxindole, compared with Agrocybe aegerita unspecific peroxygenase (/AaeUPO), when the peroxygenase is used to convert an indole to an indigo dye.
  • the peroxygenase of the present invention is preferably recombinantly produced, and comprises or consists of an amino acid sequence having at least 70% identity, preferably at least 75%, 80%, 85%, 90%, 95%, 97%, 98%, or 99% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; preferably the mature polypeptide of SEQ ID NO:1 , 2 19 or 20.
  • the peroxygenase comprises an amino acid sequence represented by the motif: E-H-D-[G,A]-S-[L,I]-S-R (SEQ ID NO: 21 ).
  • the peroxygenase comprises or consists of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; or a fragment thereof having peroxygenase activity; preferably SEQ ID NO: 1 , SEQ ID NO: 2, the mature polypeptide of SEQ ID NO: 19 or the mature polypeptide of SEQ ID NO: 20.
  • amino acid changes are of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of one to about 30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to about 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding domain.
  • conservative substitutions are within the group of basic amino acids (arginine, lysine and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine and valine), aromatic amino acids (phenylalanine, tryptophan and tyrosine), and small amino acids (glycine, alanine, serine, threonine and methionine).
  • Amino acid substitutions that do not generally alter specific activity are known in the art and are described, for example, by H. Neurath and R.L. Hill, 1979, In, The Proteins, Academic Press, New York.
  • the most commonly occurring exchanges are Ala/Ser, Val/lle, Asp/Glu, Thr/Ser, Ala/Gly, Ala/Thr, Ser/Asn, Ala/Val, Ser/Gly, Tyr/Phe, Ala/Pro, Lys/Arg, Asp/Asn, Leu/lle, LeuA al, Ala/Glu, and Asp/Gly.
  • non-standard amino acids such as 4- hydroxyproline, 6-/V-methyl lysine, 2-aminoisobutyric acid, isovaline, and alpha-methyl serine
  • a limited number of non- conservative amino acids, amino acids that are not encoded by the genetic code, and unnatural amino acids may be substituted for amino acid residues.
  • "Unnatural amino acids” have been modified after protein synthesis, and/or have a chemical structure in their side chain(s) different from that of the standard amino acids.
  • Unnatural amino acids can be chemically synthesized, and preferably, are commercially available, and include pipecolic acid, thiazolidine carboxylic acid, dehydroproline, 3- and 4-methylproline, and 3,3-dimethylproline.
  • amino acid changes are of such a nature that the physico-chemical properties of the polypeptides are altered.
  • amino acid changes may improve the thermal stability of the polypeptide, alter the substrate specificity, change the pH optimum, and the like.
  • Essential amino acids in the parent polypeptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for biological activity (i.e., peroxygenase activity) to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et al., 1996, J. Biol. Chem. 271 : 4699- 4708.
  • the active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et al., 1992, Science 255: 306-312; Smith et al., 1992, J. Mol. Biol. 224: 899-904; Wlodaver et al., 1992, FEBS Lett. 309: 59-64.
  • the identities of essential amino acids can also be inferred from analysis of identities with polypeptides that are related to a polypeptide according to the invention.
  • Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241 : 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; WO 95/17413; or WO 95/22625.
  • Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991 , Biochem. 30: 10832-10837; U.S. Patent No. 5,223,409; WO 92/06204), and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46: 145; Ner et al., 1988, DNA 1: 127).
  • Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896).
  • Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide of interest, and can be applied to polypeptides of unknown structure.
  • the peroxygenase of the present invention may be a peroxygenase variant, which comprises an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g.
  • the variant of the present invention has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
  • the variant of the present invention is a variant of a parent peroxygenase, and wherein the parent peroxygenase has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
  • the variant comprises one or more substitutions selected from the group consisting of
  • the variant comprises one or more substitutions selected from the group consisting of
  • the total number of amino acid substitutions, deletions and/or insertions of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20, is 1-20, e.g., 1 -10 and 1-5.
  • the total number of amino acid substitutions, deletions and/or insertions of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; preferably the mature polypeptide of SEQ ID NO:1 , 2, 19 or 20; is at most 10, preferably at most 9, more preferably at most 8, more preferably at most 7, more preferably at most 6, more preferably at most 5, more preferably at most 4, even more preferably at most 3, most preferably at most 2, and even most preferably at most 1 .
  • the concentration of peroxygenase is typically 0.001 mg/ml to 50 mg/ml, preferably 0.002 mg/ml to 10 mg/ml, more preferably 0.005 mg/ml to 10 mg/ml, and most preferably 0.008 mg/ml to 5 mg/ml.
  • the present invention also relates to methods for obtaining a variant having peroxygenase activity, comprising: (a) introducing into a parent peroxygenase an alteration at one or more (e.g., several) positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein the variant has peroxygenase activity; and (b) recovering the variant.
  • an alteration at one or more (e.g., several) positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54,
  • the variants can be prepared using any mutagenesis procedure known in the art, such as site-directed mutagenesis, synthetic gene construction, semi-synthetic gene construction, random mutagenesis, shuffling, etc.
  • Site-directed mutagenesis is a technique in which one or more (e.g., several) mutations are introduced at one or more defined sites in a polynucleotide encoding the parent.
  • Site-directed mutagenesis can be accomplished in vitro by PCR involving the use of oligonucleotide primers containing the desired mutation. Site-directed mutagenesis can also be performed in vitro by cassette mutagenesis involving the cleavage by a restriction enzyme at a site in the plasmid comprising a polynucleotide encoding the parent and subsequent ligation of an oligonucleotide containing the mutation in the polynucleotide. Usually the restriction enzyme that digests the plasmid and the oligonucleotide is the same, permitting sticky ends of the plasmid and the insert to ligate to one another. See, e.g., Scherer and Davis, 1979, Proc. Natl. Acad. Sci. USA 76: 4949-4955; and Barton et al., 1990, Nucleic Acids Res. 18: 7349-4966.
  • Site-directed mutagenesis can also be accomplished in vivo by methods known in the art. See, e.g., U.S. Patent Application Publication No. 2004/0171 154; Storici et al., 2001 , Nature Biotechnol. 19: 773-776; Kren et al., 1998, Nat. Med. 4: 285-290; and Calissano and Macino, 1996, Fungal Genet. Newslett. 43: 15-16.
  • Any site-directed mutagenesis procedure can be used in the present invention.
  • Synthetic gene construction entails in vitro synthesis of a designed polynucleotide molecule to encode a polypeptide of interest. Gene synthesis can be performed utilizing a number of techniques, such as the multiplex microchip-based technology described by Tian et al. (2004, Nature 432: 1050-1054) and similar technologies wherein oligonucleotides are synthesized and assembled upon photo-programmable microfluidic chips.
  • Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241 : 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; WO 95/17413; or WO 95/22625.
  • Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991 , Biochemistry 30: 10832-10837; U.S. Patent No. 5,223,409; WO 92/06204) and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46: 145; Ner ei a/., 1988, DMA 7: 127).
  • Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide.
  • Semi-synthetic gene construction is accomplished by combining aspects of synthetic gene construction, and/or site-directed mutagenesis, and/or random mutagenesis, and/or shuffling.
  • Semi-synthetic construction is typified by a process utilizing polynucleotide fragments that are synthesized, in combination with PCR techniques. Defined regions of genes may thus be synthesized de novo, while other regions may be amplified using site-specific mutagenic primers, while yet other regions may be subjected to error-prone PCR or non-error prone PCR amplification. Polynucleotide subsequences may then be shuffled.
  • the hydrogen peroxide required by the peroxygenase may be provided as an aqueous solution of hydrogen peroxide or a hydrogen peroxide precursor for in situ production of hydrogen peroxide.
  • Compounds which yield hydrogen peroxide upon dissolution in water or an appropriate aqueous based medium include but are not limited to metal peroxides, percarbonates, persulphates, perphosphates, peroxyacids, alkyperoxides, acylperoxides, peroxyesters, urea peroxide, perborates and peroxycarboxylic acids or salts thereof.
  • Another source of hydrogen peroxide is a hydrogen peroxide generating enzyme system, such as an oxidase together with a substrate for the oxidase.
  • oxidase and substrate comprise, but are not limited to, amino acid oxidase (see e.g. US 6,248,575) and a suitable amino acid, glucose oxidase (see e.g. WO 95/29996) and glucose, lactate oxidase and lactate, galactose oxidase (see e.g. WO 00/50606) and galactose, and aldose oxidase (see e.g. WO 99/31990) and a suitable aldose.
  • Another hydrogen peroxide generating enzyme system is disclosed in WO 2008/051491.
  • Oxidants which may be used with peroxygenases is oxygen combined with a suitable hydrogen donor like ascorbic acid, dehydroascorbic acid, dihydroxyfumaric acid or cysteine.
  • a suitable hydrogen donor like ascorbic acid, dehydroascorbic acid, dihydroxyfumaric acid or cysteine.
  • An example of such oxygen hydrogen donor system is described by Pasta et al., Biotechnology & Bioengineering, (1999) vol. 62, issue 4, pp. 489-493.
  • Hydrogen peroxide or a source of hydrogen peroxide may be added at the beginning of or during the method of the invention (during the reaction), e.g., as one or more separate additions or dosages of hydrogen peroxide; or continuously as fed-batch addition. If hydrogen peroxide is added during the reaction, for example as 1 mmole/min or more, the amount of hydrogen peroxide used in the reaction may correspond to a total concentration of several moles/l, depending on how long the reaction is continued. Such considerations are well known in the art, and well within the skills of a skilled person.
  • Typical amounts of hydrogen peroxide correspond to levels of from 0.001 mM to 25 mM, preferably to levels of from 0.005 mM to 5 mM, and particularly to levels of from 0.01 to 1 mM or 0.02 to 2 mM hydrogen peroxide.
  • Hydrogen peroxide may also be used in an amount corresponding to levels of from 0.1 mM to 25 mM, preferably to levels of from 0.5 mM to 15 mM, more preferably to levels of from 1 mM to 10 mM, and most preferably to levels of from 1 mM to 8 mM hydrogen peroxide.
  • the present invention provides a method for dyeing a textile, comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and an indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, SO3 " , alkyl and alkoxy.
  • indigo dye (high concentration) and sodium dithionite are used to produce an indigo dye, and indigo dye is further used to dye the textile.
  • indigo dye is not environmentally friendly, and the process is time and cost consuming.
  • the textile is dyed during production of dye in situ with a peroxygenase. So the method of the present invention is environmentally friendly, easy to handle, and time and cost efficient.
  • the method of the present invention is completely transformative and will change the conventional dyeing process.
  • the in situ dyeing method of the present invention comprises:
  • the in situ dyeing method of the present invention comprises:
  • the present invention provides a method for converting a substituted or unsubstituted indole to the corresponding 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole (or 3,3- dihydro-1 /-/-indol-2-one), comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2, 3-epoxy-1 /-/-indole, or 3-hydroxy-1 /-/-indole (or 3,3-dihydro-1 /-/-indol-2-one) may be substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3 " , alkyl and alkoxy.
  • the invention provides a method for preparing a substituted or unsubstituted indigo dye, comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3 " , alkyl and alkoxy.
  • the method is carried out in the presence of oxygen.
  • the present invention provides an environmentally friendly alternative for producing indigo dyes by using enzymes with less by-product. It does not require any harsh reaction conditions, like high temperatures or highly acid/alkaline pH. It is industrially applicable considering the yield of the indigo dyes.
  • the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20.
  • the peroxygenase comprises or consists of an amino acid sequence having at least 70% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
  • the peroxygenase comprises or consists of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; or a fragment thereof having peroxygenase activity.
  • the amino acid sequence of the peroxygenase comprises the motif: E-H-D-[G,A]- S-[L,I]-S-R (SEQ ID NO: 21 ).
  • the peroxygenase may be a peroxygenase variant, which comprises an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70% but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of S
  • the process of the present invention is flushed with nitrogen; preferably a source of hydrogen peroxide and the substituted or unsubstituted indole are mixed and flushed with nitrogen.
  • the nitrogen used in the present invention may be nitrogen from the air (from the atmosphere) or a nitrogen precursor for in situ production of nitrogen.
  • Nitrogen may be added, e.g. as pressurized atmospheric air or as pure pressurized N2.
  • nitrogen precursors may be inherently present and/or added to the effluent and which, upon dissociation or reduction, provide an in situ source of nitrogen.
  • the method of the present invention is carried out under normal atmospheric conditions.
  • the method of the present invention is carried out at pH 7-13, preferably pH 8-12, more preferably pH 9-1 1.
  • the method of the present invention is carried out in Britton- Robinson buffer, TRIS buffer or water.
  • the oxygen used to convert 3-hydroxy-1 /-/-indoles to indigos may be oxygen from the air (from the atmosphere) or an oxygen precursor for in situ production of oxygen. In many industrial applications, oxygen from the air will usually be present in sufficient quantity. If more O2 is needed, additional oxygen may be added, e.g. as pressurized atmospheric air or as pure pressurized O2. Alternatively, oxygen precursors such as peroxides may be inherently present and/or added to the effluent and which, upon dissociation or reduction, provide an in situ source of oxygen.
  • the invention also provides for use of a peroxygenase, a source of hydrogen peroxide, and an indole for in situ dyeing of a textile, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, S0 3 " , alkyl and alkoxy.
  • the invention further provides for use of a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole for preparing an indigo dye, 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole, which is unsubstituted or substituted once or twice in the benzene ring(s), and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, SO3 " , alkyl and alkoxy.
  • each substituent is independently selected from the group consisting of CI, Br, OH, NH2, COOH, and SO3 " .
  • each substituent is independently selected from the group consisting of CI, Br, OH, NH2, and SO3 " ; more preferably CI and Br.
  • the methods according to the invention may be carried out at a temperature between 10 and 90 degrees Celsius, preferably between 15 and 80 degrees Celsius, more preferably between 20 and 80 degrees Celsius, even more preferably between 20 and 70 degrees Celsius, even more preferably between 20 and 60 degrees Celsius, most preferably between 30 and 60 degrees Celsius, and in particular between 40 and 60 degrees Celsius.
  • the in situ methods of dyeing a textile of the invention may employ a treatment time of from 10 minutes to 240 minutes, preferably from 20 minutes to 180 minutes, more preferably from 30 minutes to 150 minutes, more preferably from 50 minutes to 140 minutes and in particular from 60 minutes to 120 minutes.
  • the method for converting a substituted or unsubstituted indole to the corresponding 2,3- epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole (or 3,3-dihydro-1 /-/-indol-2-one) or the method for preparing a substituted or unsubstituted indigo dye of the invention may employ a treatment time of from 5 minutes to 120 minutes, preferably from 5 minutes to 90 minutes, more preferably from 5 minutes to 60 minutes, more preferably from 5 minutes to 45 minutes, and in particular from 5 minutes to 30 minutes.
  • a method for dyeing a textile comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and an indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, S0 3 " , alkyl and alkoxy.
  • the peroxygenase has an increased selectivity for 3-hydroxy-1 /-/-indole; preferably the peroxygenase has at least 1 10%, for example, at least 150%, at least 200%, at least 300%, at least 500%, at least 800%, or at least 1000% selectivity for 3- hydroxy-1 /-/-indole, compared with Agrocybe aegerita unspecific peroxygenase, when the peroxygenase is used to convert the indole to an indigo dye.
  • each substituent is independently selected from the group consisting of CI, Br, OH, NH2, and SO3 " .
  • the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, further more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14,
  • the peroxygenase comprises or consists of an amino acid sequence having at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the amino acid sequence of SEQ ID NO: 1 , SEQ ID NO: 2, the mature polypeptide of SEQ ID NO: 19 or the mature polypeptide of SEQ ID NO: 20.
  • the peroxygenase is a peroxygenase variant, comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g.
  • the variant is a variant of a parent peroxygenase, and wherein the parent peroxygenase has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
  • a method for converting a substituted or unsubstituted indole to the corresponding 2,3- epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2, 3-epoxy-1 /-/-indole, or 3-hydroxy-1 /-/-indole is substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, S0 3 " , alkyl and alkoxy.
  • a method for preparing a substituted or unsubstituted indigo dye comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH 2 , COOH, S0 3 " , alkyl and alkoxy.
  • each substituent is independently selected from the group consisting of CI, Br, OH, NH2, and SO3 " .
  • the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, further more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, or 18, 19 or 20.
  • the peroxygenase comprises or consists of an amino acid sequence having at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the amino acid sequence of SEQ ID NO: 1 , the amino acid sequence of SEQ ID NO: 2, the mature polypeptide of SEQ ID NO: 19 or the mature polypeptide of SEQ ID NO: 20.
  • peroxygenase comprises or consists of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; or a fragment thereof having peroxygenase activity.
  • the peroxygenase is a peroxygenase variant, comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g.
  • the variant is a variant of a parent peroxygenase, and wherein the parent peroxygenase has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
  • a peroxygenase variant comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptid
  • the peroxygenase variant of paragraph 44 wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
  • the peroxygenase variant of paragraph 44 or 45 which is a variant of a parent peroxygenase, and wherein the parent peroxygenase has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
  • HiP ALS High Performance AutoSampler
  • DAD Diode Array detector
  • Fragmentor 70 V / 180 V
  • Chemicals used as buffers and substrates were commercial products of at least reagent grade.
  • Humicola insolens unspecific peroxygenase (HinUPO): disclosed as mature polypeptide of SEQ ID NO:2 in WO 2013/021061 , and as SEQ ID NO: 19 herein;
  • Daldinia caldariorum unspecific peroxygenase disclosed as mature polypeptide of SEQ ID NO:2 in WO 2014/056917, and as SEQ ID NO: 20 herein;
  • Agrocybe aegerita unspecific peroxygenase disclosed as mature polypeptide of SEQ ID NO: 1 in WO 2014/122109, and as SEQ ID NO: 1 herein;
  • Coprinopsis cinerea unspecific peroxygenase disclosed as mature polypeptide of SEQ ID NO:2 in WO 2014/122109, and as SEQ ID NO: 2 herein.
  • Example 1 Improved conversion and selectivity for an enzymatic conversion of indole to indigo using Humicola insolens unspecific peroxygenase (HinUPO) and Daldinia caldariorum unspecific peroxygenase (DcaUPO)
  • HinUPO Humicola insolens unspecific peroxygenase
  • DcaUPO Daldinia caldariorum unspecific peroxygenase
  • 1 mM substrate (indole) was converted by 0.01 mg/mL peroxygenase in 1 ml. of 50 mM phosphate buffer and 1 mM Hydrogen peroxide.
  • 5.725 mM substrate were converted by 0.01 mg/mL Humicola insolens unspecific peroxygenase (HinUPO) and variants thereof in 10 mL of 10 mM Britton-Robinson (BR, composed of phosphoric acid, acetic acid, boric acid, titrated with NaOH) buffer at different atmospheric conditions ( ) and 2 mM Hydrogen peroxide for 2 hours at room temperature.
  • HinUPO Humicola insolens unspecific peroxygenase
  • BR Britton-Robinson
  • the substrate, buffer, hydrogen peroxide mixture was flushed with nitrogen for 15 minutes.
  • the reaction was started with the addition of enzyme and nitrogen was bubbled trough the reaction over the course of the reaction.
  • the product was stirred open after reaction for 1 hour.
  • reaction under normal atmospheric conditions was conducted in a closed vessel during the reaction and after reaction stirred open for 1 hour.
  • reaction with aeration was conducted under constant air bubbling.
  • the products were stirred open after reaction for 1 hour.
  • H/ ' nUPO and the variants thereof could convert indole to an indigo dye in high yield at nitrogen atmosphere, and the variant with A55L mutation worked better than the other tested enzymes.
  • the best results in terms of obtained indigo production were received for variant with A55L mutation under normal atmospheric conditions.
  • Percentages are given on the limiting substrate. Percentages were calculated the following way: [lndigo] * 2/[H2O2] * 100 (Concentration of indigo times 2 divided by the concentration of hydrogen peroxide (limiting substrate in this case) times 100)
  • Example 3 Conversion of indole to indigo by peroxygenases at alkaline pH
  • Quantification was performed by the use of an indigo standard curve.
  • Example 7 Improved conversion and selectivity for the enzymatic conversion of 6- bromoindole to Tyrian purple using Humicola insolens unspecific peroxygenase (H/nllPO)
  • the reactions were started by the addition of limiting H2O2 (2.0-5.0 mM) and stirred at room temperature over half an hour. Rest product and 6-Br-2-oxindole were obtained, by use of HPLC, 6,6'-dibromoindigo by sulfonation.
  • Example 8 In situ dyeing process based on the conversion of 6-bromoindole to Tyrian purple catalyzed by Coprinopsis cinerea unspecific peroxygenase (Cc/UPO)
  • Example 9 In situ dyeing process based on the conversion of 6-bromoindole to Tyrian purple catalyzed by Agrocybe aegerita peroxygenase
  • 6-bromoindole (1 mM, dissolved in 50/50 v/v acetonitrile/water (ACN/H2O), ACN final concentration was reduced to 2.5%) was converted by 0.025 ⁇ g/mL Agrocybe aegerita peroxygenase (/AaeUPO) in 5 L of 50 mM potassium phosphate buffer (pH 7). Total reaction volume was 10 Liter.
  • the same reactor was used as in example 8 (steel tank with a volume of 25 L). The reactor was placed on a laboratory shaker. Prior to hydrogen peroxide addition that initiated the dyeing reaction, about 200 g cotton fabric (two white T-shirts) were added to the reaction mixture.
  • the reaction was started by the addition of a first portion of hydrogen peroxide (1 .25 mM, then continued to 5 mM H2O2 final concentration added in four portion every half an hour).
  • the reactor was shaken with a rotation speed of 180 rpm.
  • the cotton fabric was removed from the reactor, washed under running water and air-dried.
  • the originally white fabric turns its color to purple (color intermediate between red and blue); the color is identical to that of Tyrian purple (also known as imperial purple), a natural dye that is prepared from sea snails of the family Muricidae.
  • the experimental process was analogous to example 8.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Textile Engineering (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Coloring (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention relates to use of a peroxygenase for preparing indigo dyes and an in situ method for dyeing a textile with indigo dyes.

Description

ENZYMATIC PREPARATION OF INDIGO DYES AND IN SITU DYEING PROCESS
Reference to a Sequence Listing
This application contains a Sequence Listing in computer readable form. The computer readable form is incorporated herein by reference.
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to use of a peroxygenase for preparing indigo dyes and an in situ method for dyeing a textile with indigo dyes.
Background
Indigo dye is an organic compound with a distinctive blue color. Historically, indigo was a natural dye extracted from plants, and this process was important economically because blue dyes were once rare. Nearly all indigo dye produced today - several thousand tons each year - is synthetic. Indigo is the blue of blue jeans.
The primary use for indigo is as a dye for cotton yarn, which is mainly for the production of denim cloth for blue jeans. On average, a pair of blue jean trousers requires 3 - 12 g of indigo. Small amounts are used for dyeing wool and silk.
Indigo is insoluble in water. Therefore, the dye powder must be reduced to the soluble leuco form using sodium dithionite as reduction agents and alkali (for example, sodium hydroxide). The textile is then dipped into the dyeing bath containing the reduced leuco indigo and subsequently exposed to air to let the indigo oxidize. Since the dye take up is limited, this process is repeated 6 - 8 times in consecutive arranged tanks. Here, the consumption of reduction agent is increasing over each step and waste water containing sulfate is produced.
Another possibility is the use of pre-reduced indigo which is reduced at the dye manufacturer and then shipped in inert containers to the dyeing house.
The chemistry used for producing indigo is quite harsh and not very environmentally friendly. It comprises the use of high temperature and molten alkali.
WO 2014/122109 discloses a method for preparing an indigo dye, comprising contacting an indole with a peroxygenase and a source of hydrogen peroxide.
However, there is still a need for a more efficient method for producing an indigo dye to improve the process economics. Furthermore, there is still a need for an improved method for dyeing a textile with an indigo dye. The present invention aims to meet the needs.
SUMMARY OF THE INVENTION
In one aspect, the present invention provides a method for dyeing a textile, comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and a substituted or unsubstituted indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
In another aspect, the present invention provides a method or process for converting a substituted or unsubstituted indole to the corresponding 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/- indole, comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2,3-epoxy-1 /-/- indole or 3-hydroxy-1 /-/-indole may be substituted once or twice in the benzene ring (the aromatic ring) and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
In another aspect, the invention provides a method for preparing a substituted or unsubstituted indigo dye, comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring (the aromatic ring) and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
In embodiments, the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20. In other embodiments, the amino acid sequence comprises the motif: E-H-D-[G,A]-S-[L,I]-S-R.
Other aspects and embodiments of the invention are apparent from the description and examples. DEFINITIONS
Peroxygenase: The term "peroxygenase" means an enzyme exhibiting "unspecific peroxygenase" activity according to EC 1.1 1.2.1 , that catalyzes insertion of an oxygen atom from H2O2 into a variety of substrates, such as nitrobenzodioxole. For purposes of the present invention, peroxygenase activity is determined according to the procedure described in M. Poraj- Kobielska, M. Kinne, R. Ullrich, K. Scheibner, M. Hofrichter, "A spectrophotometric assay for the detection of fungal peroxygenases", Analytical Biochemistry (2012), vol. 421 , issue 1 , pp. 327- 329.
The peroxygenase of the present invention has at least 20%, preferably at least 40%, more preferably at least 50%, more preferably at least 60%, more preferably at least 70%, more preferably at least 80%, even more preferably at least 90%, most preferably at least 95%, most preferably at least 100%, most preferably at least 120%, and even most preferably at least 150% of the peroxygenase activity of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20.
Mature polypeptide: The term "mature polypeptide" is defined herein as a polypeptide having peroxygenase activity that is in its final form following translation and any post-translational modifications, such as N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, etc. In a preferred aspect, the mature polypeptide has the amino acid sequence shown in positions 1 to 328 of SEQ ID NO: 1 based on the N-terminal peptide sequencing data (Ullrich et al., 2004, Appl. Env. Microbiol. 70(8): 4575-4581 ), elucidating the start of the mature protein of AaeAPO peroxygenase enzyme.
Identity: The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter "identity".
For purposes of the present invention, the degree of identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends in Genetics 16: 276-277; http://emboss.org), preferably version 5.0.0 or later. The optional parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. The output of Needle labeled "longest identity" (obtained using the -nobrief option) is used as the percent identity and is calculated as follows:
(Identical Residues x 100)/(Length of Alignment - Total Number of Gaps in Alignment)
Parent or parent peroxygenase: The term "parent" or "parent peroxygenase" means any polypeptide with peroxygenase activity to which an alteration is made to produce the enzyme variants of the present invention.
Variant: The term "variant" means a polypeptide having peroxygenase activity comprising an alteration, i.e., a substitution, insertion, and/or deletion, at one or more (e.g., several) positions. A substitution means replacement of the amino acid occupying a position with a different amino acid; a deletion means removal of the amino acid occupying a position; and an insertion means adding an amino acid adjacent to and immediately following the amino acid occupying a position The variants of the present invention have at least 20%, e.g., at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 100%, at least 120%, or at least 150% of the peroxygenase activity of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20.
Conventions for Designation of Variants
For purposes of the present invention, the mature polypeptide disclosed in SEQ ID NO: 19 is used to determine the corresponding amino acid residue in another peroxygenase. The amino acid sequence of another peroxygenase is aligned with the mature polypeptide disclosed in SEQ ID NO: 19, and based on the alignment, the amino acid position number corresponding to any amino acid residue in the mature polypeptide disclosed in SEQ ID NO: 19 is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277), preferably version 5.0.0 or later. The parameters used are gap open penalty of 10, gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
Identification of the corresponding amino acid residue in another peroxygenase can be determined by an alignment of multiple polypeptide sequences using several computer programs including, but not limited to, MUSCLE (multiple sequence comparison by log - expectation; version 3.5 or later; Edgar, 2004, Nucleic Acids Research 32: 1792-1797), MAFFT (version 6.857 or later; Katoh and Kuma, 2002, Nucleic Acids Research 30: 3059-3066; Katoh et al., 2005, Nucleic Acids Research 33: 51 1 -518; Katoh and Toh, 2007, Bioinformatics 23: 372-374; Katoh et al., 2009, Methods in Molecular Biology 537: 39-64; Katoh and Toh, 2010, Bioinformatics 26: 1899-1900), and EMBOSS EMMA employing ClustalW (1.83 or later; Thompson et al., 1994, Nucleic Acids Research 22: 4673-4680), using their respective default parameters.
When the other enzyme has diverged from the mature polypeptide of SEQ ID NO: 19 such that traditional sequence-based comparison fails to detect their relationship (Lindahl and Elofsson, 2000, J. Mol. Biol. 295: 613-615), other pairwise sequence comparison algorithms can be used. Greater sensitivity in sequence-based searching can be attained using search programs that utilize probabilistic representations of polypeptide families (profiles) to search databases. For example, the PSI-BLAST program generates profiles through an iterative database search process and is capable of detecting remote homologs (Atschul et al., 1997, Nucleic Acids Res. 25: 3389-3402). Even greater sensitivity can be achieved if the family or superfamily for the polypeptide has one or more representatives in the protein structure databases. Programs such as GenTHREADER (Jones, 1999, J. Mol. Biol. 287: 797-815; McGuffin and Jones, 2003, Bioinformatics 19: 874-881 ) utilize information from a variety of sources (PSI-BLAST, secondary structure prediction, structural alignment profiles, and solvation potentials) as input to a neural network that predicts the structural fold for a query sequence. Similarly, the method of Gough et al., 2000, J. Mol. Biol. 313: 903-919, can be used to align a sequence of unknown structure with the superfamily models present in the SCOP database. These alignments can in turn be used to generate homology models for the polypeptide, and such models can be assessed for accuracy using a variety of tools developed for that purpose.
For proteins of known structure, several tools and resources are available for retrieving and generating structural alignments. For example the SCOP superfamilies of proteins have been structurally aligned, and those alignments are accessible and downloadable. Two or more protein structures can be aligned using a variety of algorithms such as the distance alignment matrix (Holm and Sander, 1998, Proteins 33: 88-96) or combinatorial extension (Shindyalov and Bourne, 1998, Protein Engineering 1 1 : 739-747), and implementation of these algorithms can additionally be utilized to query structure databases with a structure of interest in order to discover possible structural homologs (e.g., Holm and Park, 2000, Bioinformatics 16: 566-567).
In describing the variants of the present invention, the nomenclature described below is adapted for ease of reference. The accepted lUPAC single letter or three letter amino acid abbreviation is employed.
Substitutions. For an amino acid substitution, the following nomenclature is used: Original amino acid, position, substituted amino acid. Accordingly, the substitution of threonine at position 226 with alanine is designated as "Thr226Ala" or "T226A". Multiple mutations are separated by addition marks ("+"), e.g., "Gly205Arg + Ser41 1 Phe" or "G205R + S41 1 F", representing substitutions at positions 205 and 41 1 of glycine (G) with arginine (R) and serine (S) with phenylalanine (F), respectively.
Deletions. For an amino acid deletion, the following nomenclature is used: Original amino acid, position, *. Accordingly, the deletion of glycine at position 195 is designated as "Gly195*" or "G195*". Multiple deletions are separated by addition marks ("+"), e.g. , "Gly195* + Ser41 1 *" or "G195* + S41 1 *".
Insertions. For an amino acid insertion, the following nomenclature is used: Original amino acid, position, original amino acid, inserted amino acid. Accordingly the insertion of lysine after glycine at position 195 is designated "Gly195Glyl_ys" or "G195GK". An insertion of multiple amino acids is designated [Original amino acid, position, original amino acid, inserted amino acid #1 , inserted amino acid #2; etc.]. For example, the insertion of lysine and alanine after glycine at position 195 is indicated as "Gly195Glyl_ysAla" or "G195GKA".
In such cases the inserted amino acid residue(s) are numbered by the addition of lower case letters to the position number of the amino acid residue preceding the inserted amino acid residue(s). In the above example, the sequence would thus be:
Figure imgf000006_0001
Multiple alterations. Variants comprising multiple alterations are separated by addition marks ("+"), e.g., "Arg170Tyr+Gly195Glu" or "R170Y+G195E" representing a substitution of arginine and glycine at positions 170 and 195 with tyrosine and glutamic acid, respectively.
Different alterations. Where different alterations can be introduced at a position, the different alterations are separated by a comma, e.g., "Arg170Tyr,Glu" represents a substitution of arginine at position 170 with tyrosine or glutamic acid. Thus, "Tyr167Gly,Ala + Arg170Gly,Ala" designates the following variants:
"Tyr167Gly+Arg170Gly", "Tyr167Gly+Arg170Ala", "Tyr167Ala+Arg170Gly", and "Tyr167Ala+Arg170Ala". Wild-type peroxygenase: The term "wild-type" peroxygenase means a peroxygenase expressed by a naturally occurring microorganism, such as a bacterium, yeast, or filamentous fungus found in nature.
Alkyl: The term "alkyl" in the present context represents a linear or branched hydrocarbon radical having 1 -3 carbon atoms. Representative examples include methyl, ethyl, n-propyl and /'so-propyl.
Alkoxy: The term "alkoxy" in the present context represents a radical of the formula -OR, where R is alkyl as defined above. Representative examples include methoxy, ethoxy, n-propoxy and /'so-propoxy.
Textile: The term "textiles" used herein is meant to include fibers, yarns, fabrics and garments.
Fabric can be constructed from fibers by weaving, knitting or non-woven operations. Weaving and knitting require yarn as the input whereas the non-woven fabric is the result of random bonding of fibers (paper can be thought of as non-woven). In the present context, the term "fabric" is also intended to include fibers and other types of processed fabrics.
According to the invention, the method of the invention may be applied to any textile known in the art (woven, knitted, or non-woven). In particular the process of the present invention may be applied to cellulose-containing or cellulosic textile, such as cotton, viscose, rayon, ramie, linen, lyocell (e.g., Tencel, produced by Courtaulds Fibers), or mixtures thereof, or mixtures of any of these fibers together with synthetic fibres (e.g., polyester, polyamid, nylon) or other natural fibers such as wool and silk., such as viscose/cotton blends, lyocell/cotton blends, viscose/wool blends, lyocell/wool blends, cotton/wool blends; flax (linen), ramie and other fabrics based on cellulose fibers, including all blends of cellulosic fibers with other fibers such as wool, polyamide, acrylic and polyester fibers, e.g., viscose/cotton/polyester blends, wool/cotton/polyester blends, flax/cotton blends etc.
DETAILED DESCRIPTION OF THE INVENTION
In one aspect, the present invention provides a method for dyeing a textile, comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and an indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3", alkyl and alkoxy.
In another aspect, the present invention provides a method or process for converting a substituted or unsubstituted indole to the corresponding 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/- indole, comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2,3-epoxy-1 /-/- indole or 3-hydroxy-1 /-/-indole may be substituted once or twice in the benzene ring (the aromatic ring) and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
In another aspect, the invention provides a method for preparing a substituted or unsubstituted indigo dye, comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring (the aromatic ring) and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3", alkyl and alkoxy. Indole (or 1 /-/-indole) and indole derivates (such as indole, 6-bromoindole, 6-chloroindole, 4-chloroindole, 5-chloroindole and 5-bromoindole) can be epoxidized to 2, 3-epoxy-1 /-/-indole (and corresponding derivates) using peroxygenases ("APO/UPO") and hydrogen peroxide. 2, 3-Epoxy-1 /-/-indole further rearranges to 3-hydroxy-1 /-/- indole (may be referred to as indoxyl), which spontaneously is oxidized by oxygen (for example from air) to form indigo. The 1 /-/-indoles may contain 1 or 2, the same or different substituents R, where R may be F, CI, Br, OH, NH2, COOH (carboxyl), S03 " (sulfonate), alkyl or alkoxy.
Figure imgf000008_0001
(1 ) 1 /-/-indoles; (2) 2, 3-epoxy-1 /-/-indoles; (3) 3,3-dihydro-1 /-/-indol-2-ones; (4) 3-hydroxy-1 /-/- indoles; (5) indigos: R = H (indigo), R = Br (6,6'-dibromoindigo), R = CI (6,6'-dichloroindigo). "APO" = aromatic peroxygenase, and "UPO" = unspecific peroxygenase.
Non-substituted 1 /-/-indole (or indole) produces indigo and 3,3-dihydro-1 /-/-indol-2-ones (may be referred to as 2-oxindol or 2-oxindole), while derivatives of indole produce a variety of purple, violet, and red colors. 6,6'-dibromoindigo is also known as tyrian purple.
Peroxygenase
The peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole. In one embodiment, the peroxygenase has at least 1 10%, for example, at least 150%, at least 200%, at least 300%, at least 500%, at least 800%, or at least 1000% selectivity for 3-hydroxy-1 /-/-indole, compared with Agrocybe aegerita unspecific peroxygenase (/AaeUPO), when the peroxygenase is used to convert an indole to an indigo dye.
In another embodiment, the peroxygenase having an increased selectivity for 3-hydroxy- 1 /-/-indole has a decreased selectivity for 2-oxindole. In a specific embodiment, the peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole has about 1 -90%, for example, about 5- 80%, about 10-70%, or about 15-60% selectivity for 2-oxindole, compared with Agrocybe aegerita unspecific peroxygenase (/AaeUPO), when the peroxygenase is used to convert an indole to an indigo dye.
The peroxygenase of the present invention is preferably recombinantly produced, and comprises or consists of an amino acid sequence having at least 70% identity, preferably at least 75%, 80%, 85%, 90%, 95%, 97%, 98%, or 99% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; preferably the mature polypeptide of SEQ ID NO:1 , 2 19 or 20.
In a preferred embodiment, the peroxygenase comprises an amino acid sequence represented by the motif: E-H-D-[G,A]-S-[L,I]-S-R (SEQ ID NO: 21 ).
In yet another embodiment, the peroxygenase comprises or consists of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; or a fragment thereof having peroxygenase activity; preferably SEQ ID NO: 1 , SEQ ID NO: 2, the mature polypeptide of SEQ ID NO: 19 or the mature polypeptide of SEQ ID NO: 20.
Preferably, amino acid changes are of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of one to about 30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to about 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding domain.
Examples of conservative substitutions are within the group of basic amino acids (arginine, lysine and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine and valine), aromatic amino acids (phenylalanine, tryptophan and tyrosine), and small amino acids (glycine, alanine, serine, threonine and methionine). Amino acid substitutions that do not generally alter specific activity are known in the art and are described, for example, by H. Neurath and R.L. Hill, 1979, In, The Proteins, Academic Press, New York. The most commonly occurring exchanges are Ala/Ser, Val/lle, Asp/Glu, Thr/Ser, Ala/Gly, Ala/Thr, Ser/Asn, Ala/Val, Ser/Gly, Tyr/Phe, Ala/Pro, Lys/Arg, Asp/Asn, Leu/lle, LeuA al, Ala/Glu, and Asp/Gly.
In addition to the 20 standard amino acids, non-standard amino acids (such as 4- hydroxyproline, 6-/V-methyl lysine, 2-aminoisobutyric acid, isovaline, and alpha-methyl serine) may be substituted for amino acid residues of a wild-type polypeptide. A limited number of non- conservative amino acids, amino acids that are not encoded by the genetic code, and unnatural amino acids may be substituted for amino acid residues. "Unnatural amino acids" have been modified after protein synthesis, and/or have a chemical structure in their side chain(s) different from that of the standard amino acids. Unnatural amino acids can be chemically synthesized, and preferably, are commercially available, and include pipecolic acid, thiazolidine carboxylic acid, dehydroproline, 3- and 4-methylproline, and 3,3-dimethylproline.
Alternatively, the amino acid changes are of such a nature that the physico-chemical properties of the polypeptides are altered. For example, amino acid changes may improve the thermal stability of the polypeptide, alter the substrate specificity, change the pH optimum, and the like.
Essential amino acids in the parent polypeptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for biological activity (i.e., peroxygenase activity) to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et al., 1996, J. Biol. Chem. 271 : 4699- 4708. The active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et al., 1992, Science 255: 306-312; Smith et al., 1992, J. Mol. Biol. 224: 899-904; Wlodaver et al., 1992, FEBS Lett. 309: 59-64. The identities of essential amino acids can also be inferred from analysis of identities with polypeptides that are related to a polypeptide according to the invention.
Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241 : 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; WO 95/17413; or WO 95/22625. Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991 , Biochem. 30: 10832-10837; U.S. Patent No. 5,223,409; WO 92/06204), and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46: 145; Ner et al., 1988, DNA 1: 127).
Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide of interest, and can be applied to polypeptides of unknown structure.
In an embodiment, the peroxygenase of the present invention may be a peroxygenase variant, which comprises an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g. , at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
In another embodiment, the variant of the present invention has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
In a further embodiment, the variant of the present invention is a variant of a parent peroxygenase, and wherein the parent peroxygenase has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
In a further embodiment, the variant comprises one or more substitutions selected from the group consisting of
W5F
E6K,C
K1 1 N,C
M19L,G
H26N,Q,A
F28Y,L,V
R34K
K39Q
G44A
N52Q
T54A
A55L,V,F,I
A58L,V,F,S,I
L59I
F62V,L,A,G
M65T,L
N71 Q N78D
H83N
I85F,L,V
L86F
N106Q
K107C
T108A
W117F
S120G
F147T
M148L
L151 G,F,A,V
G152A.Q
N153D
I154V,T,A
F155I.V
T156C
G158A,T,F,L
E159D
A162F,L,I,V
Y163D.L
M165I.L
L166V
I167L
W179F
W183I.V.F
F184I.V.L
W195F
K200E
E201 S
V206H
A209T
Q215R, and
N216Q.
In a further embodiment, the variant comprises one or more substitutions selected from the group consisting of
A55L N71 Q
1154V
W183I
W183V
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+S120G+F147T+N153D+M16 5I+L166V+1167L+K200E+E201 S+V206H+A209T+Q215R
G158A+W183V
G158A+W183I
L151A+G158A
L151A+W183V
K107C+T108A
I85V+M165L
M165L+W179F
W117F+W195F
E6C+W1 17F; and
L151A+W183I.
The total number of amino acid substitutions, deletions and/or insertions of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20, is 1-20, e.g., 1 -10 and 1-5. In a preferable embodiment, the total number of amino acid substitutions, deletions and/or insertions of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; preferably the mature polypeptide of SEQ ID NO:1 , 2, 19 or 20; is at most 10, preferably at most 9, more preferably at most 8, more preferably at most 7, more preferably at most 6, more preferably at most 5, more preferably at most 4, even more preferably at most 3, most preferably at most 2, and even most preferably at most 1 .
The concentration of peroxygenase is typically 0.001 mg/ml to 50 mg/ml, preferably 0.002 mg/ml to 10 mg/ml, more preferably 0.005 mg/ml to 10 mg/ml, and most preferably 0.008 mg/ml to 5 mg/ml.
Preparation of Variants
The present invention also relates to methods for obtaining a variant having peroxygenase activity, comprising: (a) introducing into a parent peroxygenase an alteration at one or more (e.g., several) positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein the variant has peroxygenase activity; and (b) recovering the variant.
The variants can be prepared using any mutagenesis procedure known in the art, such as site-directed mutagenesis, synthetic gene construction, semi-synthetic gene construction, random mutagenesis, shuffling, etc.
Site-directed mutagenesis is a technique in which one or more (e.g., several) mutations are introduced at one or more defined sites in a polynucleotide encoding the parent.
Site-directed mutagenesis can be accomplished in vitro by PCR involving the use of oligonucleotide primers containing the desired mutation. Site-directed mutagenesis can also be performed in vitro by cassette mutagenesis involving the cleavage by a restriction enzyme at a site in the plasmid comprising a polynucleotide encoding the parent and subsequent ligation of an oligonucleotide containing the mutation in the polynucleotide. Usually the restriction enzyme that digests the plasmid and the oligonucleotide is the same, permitting sticky ends of the plasmid and the insert to ligate to one another. See, e.g., Scherer and Davis, 1979, Proc. Natl. Acad. Sci. USA 76: 4949-4955; and Barton et al., 1990, Nucleic Acids Res. 18: 7349-4966.
Site-directed mutagenesis can also be accomplished in vivo by methods known in the art. See, e.g., U.S. Patent Application Publication No. 2004/0171 154; Storici et al., 2001 , Nature Biotechnol. 19: 773-776; Kren et al., 1998, Nat. Med. 4: 285-290; and Calissano and Macino, 1996, Fungal Genet. Newslett. 43: 15-16.
Any site-directed mutagenesis procedure can be used in the present invention. There are many commercial kits available that can be used to prepare variants.
Synthetic gene construction entails in vitro synthesis of a designed polynucleotide molecule to encode a polypeptide of interest. Gene synthesis can be performed utilizing a number of techniques, such as the multiplex microchip-based technology described by Tian et al. (2004, Nature 432: 1050-1054) and similar technologies wherein oligonucleotides are synthesized and assembled upon photo-programmable microfluidic chips.
Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241 : 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; WO 95/17413; or WO 95/22625. Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991 , Biochemistry 30: 10832-10837; U.S. Patent No. 5,223,409; WO 92/06204) and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46: 145; Ner ei a/., 1988, DMA 7: 127).
Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide.
Semi-synthetic gene construction is accomplished by combining aspects of synthetic gene construction, and/or site-directed mutagenesis, and/or random mutagenesis, and/or shuffling. Semi-synthetic construction is typified by a process utilizing polynucleotide fragments that are synthesized, in combination with PCR techniques. Defined regions of genes may thus be synthesized de novo, while other regions may be amplified using site-specific mutagenic primers, while yet other regions may be subjected to error-prone PCR or non-error prone PCR amplification. Polynucleotide subsequences may then be shuffled.
Source of hydrogen peroxide
The hydrogen peroxide required by the peroxygenase may be provided as an aqueous solution of hydrogen peroxide or a hydrogen peroxide precursor for in situ production of hydrogen peroxide. Any solid entity which liberates upon dissolution a peroxide, which is useable by peroxygenase, can serve as a source of hydrogen peroxide. Compounds which yield hydrogen peroxide upon dissolution in water or an appropriate aqueous based medium include but are not limited to metal peroxides, percarbonates, persulphates, perphosphates, peroxyacids, alkyperoxides, acylperoxides, peroxyesters, urea peroxide, perborates and peroxycarboxylic acids or salts thereof.
Another source of hydrogen peroxide is a hydrogen peroxide generating enzyme system, such as an oxidase together with a substrate for the oxidase. Examples of combinations of oxidase and substrate comprise, but are not limited to, amino acid oxidase (see e.g. US 6,248,575) and a suitable amino acid, glucose oxidase (see e.g. WO 95/29996) and glucose, lactate oxidase and lactate, galactose oxidase (see e.g. WO 00/50606) and galactose, and aldose oxidase (see e.g. WO 99/31990) and a suitable aldose. Another hydrogen peroxide generating enzyme system is disclosed in WO 2008/051491.
By studying EC 1.1.3._, EC 1.2.3._, EC 1.4.3._, and EC 1.5.3._ or similar classes (under the International Union of Biochemistry), other examples of such combinations of oxidases and substrates are easily recognized by one skilled in the art.
Alternative oxidants which may be used with peroxygenases is oxygen combined with a suitable hydrogen donor like ascorbic acid, dehydroascorbic acid, dihydroxyfumaric acid or cysteine. An example of such oxygen hydrogen donor system is described by Pasta et al., Biotechnology & Bioengineering, (1999) vol. 62, issue 4, pp. 489-493.
Hydrogen peroxide or a source of hydrogen peroxide may be added at the beginning of or during the method of the invention (during the reaction), e.g., as one or more separate additions or dosages of hydrogen peroxide; or continuously as fed-batch addition. If hydrogen peroxide is added during the reaction, for example as 1 mmole/min or more, the amount of hydrogen peroxide used in the reaction may correspond to a total concentration of several moles/l, depending on how long the reaction is continued. Such considerations are well known in the art, and well within the skills of a skilled person. Typical amounts of hydrogen peroxide (concentrations of hydrogen peroxide, which may be supplemented with more hydrogen peroxide when depleted during the reaction) correspond to levels of from 0.001 mM to 25 mM, preferably to levels of from 0.005 mM to 5 mM, and particularly to levels of from 0.01 to 1 mM or 0.02 to 2 mM hydrogen peroxide. Hydrogen peroxide may also be used in an amount corresponding to levels of from 0.1 mM to 25 mM, preferably to levels of from 0.5 mM to 15 mM, more preferably to levels of from 1 mM to 10 mM, and most preferably to levels of from 1 mM to 8 mM hydrogen peroxide.
Methods, Compositions and Uses
In one aspect, the present invention provides a method for dyeing a textile, comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and an indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3", alkyl and alkoxy.
In a conventional dyeing process with indigo dyes, high temperature, sodium hydroxide
(high concentration) and sodium dithionite are used to produce an indigo dye, and indigo dye is further used to dye the textile. This is not environmentally friendly, and the process is time and cost consuming. By the method of the present invention, the textile is dyed during production of dye in situ with a peroxygenase. So the method of the present invention is environmentally friendly, easy to handle, and time and cost efficient. The method of the present invention is completely transformative and will change the conventional dyeing process.
In an embodiment, the in situ dyeing method of the present invention comprises:
(a) contacting the textile with a peroxygenase, and an indole; and
(b) adding a source of hydrogen peroxide in one or more dosages.
In another embodiment, the in situ dyeing method of the present invention comprises:
(a) contacting the textile with a source of hydrogen peroxide, and an indole; and
(b) adding a peroxygenase.
In another aspect, the present invention provides a method for converting a substituted or unsubstituted indole to the corresponding 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole (or 3,3- dihydro-1 /-/-indol-2-one), comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2, 3-epoxy-1 /-/-indole, or 3-hydroxy-1 /-/-indole (or 3,3-dihydro-1 /-/-indol-2-one) may be substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3", alkyl and alkoxy.
In another aspect, the invention provides a method for preparing a substituted or unsubstituted indigo dye, comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3", alkyl and alkoxy. In an embodiment, the method is carried out in the presence of oxygen.
The present invention provides an environmentally friendly alternative for producing indigo dyes by using enzymes with less by-product. It does not require any harsh reaction conditions, like high temperatures or highly acid/alkaline pH. It is industrially applicable considering the yield of the indigo dyes.
In an embodiment, the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20. In preferred embodiments, the peroxygenase comprises or consists of an amino acid sequence having at least 70% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20. In more preferred embodiments, the peroxygenase comprises or consists of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; or a fragment thereof having peroxygenase activity. In other embodiments, the amino acid sequence of the peroxygenase comprises the motif: E-H-D-[G,A]- S-[L,I]-S-R (SEQ ID NO: 21 ).
In an embodiment, the peroxygenase may be a peroxygenase variant, which comprises an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70% but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
In an embodiment, the process of the present invention is flushed with nitrogen; preferably a source of hydrogen peroxide and the substituted or unsubstituted indole are mixed and flushed with nitrogen.
The nitrogen used in the present invention may be nitrogen from the air (from the atmosphere) or a nitrogen precursor for in situ production of nitrogen. Nitrogen may be added, e.g. as pressurized atmospheric air or as pure pressurized N2. Alternatively, nitrogen precursors may be inherently present and/or added to the effluent and which, upon dissociation or reduction, provide an in situ source of nitrogen.
In a further embodiment, the method of the present invention is carried out under normal atmospheric conditions.
In a further embodiment, the method of the present invention is carried out at pH 7-13, preferably pH 8-12, more preferably pH 9-1 1. In an even further embodiment, the method of the present invention is carried out in Britton- Robinson buffer, TRIS buffer or water.
The oxygen used to convert 3-hydroxy-1 /-/-indoles to indigos may be oxygen from the air (from the atmosphere) or an oxygen precursor for in situ production of oxygen. In many industrial applications, oxygen from the air will usually be present in sufficient quantity. If more O2 is needed, additional oxygen may be added, e.g. as pressurized atmospheric air or as pure pressurized O2. Alternatively, oxygen precursors such as peroxides may be inherently present and/or added to the effluent and which, upon dissociation or reduction, provide an in situ source of oxygen.
The invention also provides for use of a peroxygenase, a source of hydrogen peroxide, and an indole for in situ dyeing of a textile, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
The invention further provides for use of a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole for preparing an indigo dye, 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole, which is unsubstituted or substituted once or twice in the benzene ring(s), and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3", alkyl and alkoxy.
In an embodiment, each substituent is independently selected from the group consisting of CI, Br, OH, NH2, COOH, and SO3". Preferably, each substituent is independently selected from the group consisting of CI, Br, OH, NH2, and SO3"; more preferably CI and Br.
The methods according to the invention may be carried out at a temperature between 10 and 90 degrees Celsius, preferably between 15 and 80 degrees Celsius, more preferably between 20 and 80 degrees Celsius, even more preferably between 20 and 70 degrees Celsius, even more preferably between 20 and 60 degrees Celsius, most preferably between 30 and 60 degrees Celsius, and in particular between 40 and 60 degrees Celsius.
The in situ methods of dyeing a textile of the invention may employ a treatment time of from 10 minutes to 240 minutes, preferably from 20 minutes to 180 minutes, more preferably from 30 minutes to 150 minutes, more preferably from 50 minutes to 140 minutes and in particular from 60 minutes to 120 minutes.
The method for converting a substituted or unsubstituted indole to the corresponding 2,3- epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole (or 3,3-dihydro-1 /-/-indol-2-one) or the method for preparing a substituted or unsubstituted indigo dye of the invention may employ a treatment time of from 5 minutes to 120 minutes, preferably from 5 minutes to 90 minutes, more preferably from 5 minutes to 60 minutes, more preferably from 5 minutes to 45 minutes, and in particular from 5 minutes to 30 minutes.
The invention is further defined in the following paragraphs:
[1 ]. A method for dyeing a textile, comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and an indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
[2]. The method of paragraph 1 , wherein the peroxygenase has an increased selectivity for 3-hydroxy-1 /-/-indole; preferably the peroxygenase has at least 1 10%, for example, at least 150%, at least 200%, at least 300%, at least 500%, at least 800%, or at least 1000% selectivity for 3- hydroxy-1 /-/-indole, compared with Agrocybe aegerita unspecific peroxygenase, when the peroxygenase is used to convert the indole to an indigo dye.
[3]. The method of paragraph 1 or 2, wherein each substituent is independently selected from the group consisting of CI, Br, OH, NH2, COOH, and S03 ".
[4]. The method of paragraph 3, wherein each substituent is independently selected from the group consisting of CI, Br, OH, NH2, and SO3".
[5]. The method paragraph 1 , wherein the indole is an indole or an indole substituted with
Br.
[6]. The method of any of paragraphs 1 -5, comprising:
(a) contacting the textile with a peroxygenase, and an indole; and
(b) adding a source of hydrogen peroxide in one or more dosages.
[7]. The method of any of paragraphs 1 -5, comprising:
(a) contacting the textile with a source of hydrogen peroxide, and an indole; and
(b) adding a peroxygenase.
[8]. The method of any of paragraphs 1-7, wherein the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, further more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14,
15, 16, 17, or 18, 19 or 20.
[9]. The method of any of paragraphs 1-8, wherein the peroxygenase comprises or consists of an amino acid sequence having at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the amino acid sequence of SEQ ID NO: 1 , SEQ ID NO: 2, the mature polypeptide of SEQ ID NO: 19 or the mature polypeptide of SEQ ID NO: 20.
[10]. The method of any of paragraphs 1-9, wherein the amino acid sequence of the peroxygenase comprises the motif: E-H-D-[G,A]-S-[L,I]-S-R (SEQ ID NO: 21 ).
[1 1]. The method of any of paragraphs 1-10, wherein the peroxygenase comprises or consists of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15,
16, 17, 18, 19 or 20; or a fragment thereof having peroxygenase activity. [12]. The method of any of paragraphs 1-1 1 , wherein the peroxygenase is a peroxygenase variant, comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g. , at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[13]. The method of 12, wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[14]. The method of paragraph 12 or 13, wherein the variant is a variant of a parent peroxygenase, and wherein the parent peroxygenase has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[15]. The method of any of paragraphs 12-14, wherein the variant comprises one or more substitutions selected from the group consisting of
W5F
E6K,C
K1 1 N,C
M19L,G
H26N,Q,A
F28Y,L,V
R34K
K39Q
G44A
N52Q
T54A
A55L,V,F,I
A58L,V,F,S,I
L59I
F62V,L,A,G M65T.L
N71 Q
N78D
H83N
I85F,L,V
L86F
N106Q
K107C
T108A
W117F
S120G
F147T
M148L
L151 G,F,A,V
G152A.Q
N153D
I154V,T,A
F155I.V
T156C
G158A,T,F,L
E159D
A162F,L,I,V
Y163D.L
M165I.L
L166V
I167L
W179F
W183I.V.F
F184I.V.L
W195F
K200E
E201 S
V206H
A209T
Q215R, and [16]. The method of any of paragraphs 12-15, wherein the variant comprises one or more substitutions selected from the group consisting of
A55L
N71 Q
1154V
W183I
W183V
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+S120G+F147T+N153D+M165I+ L166V+1167L+K200E+E201 S+V206H+A209T+Q215R
G158A+W183V
G158A+W183I
L151A+G158A
L151A+W183V
K107C+T108A
I85V+M165L
M165L+W179F
W117F+W195F
E6C+W1 17F; and
L151A+W183I.
[17]. The method of any paragraphs 1-16, which is flushed with nitrogen; preferably a source of hydrogen peroxide and the substituted or unsubstituted indole are mixed and flushed with nitrogen.
[18]. The method of any of paragraphs 1 -17, which is carried out under normal atmospheric conditions.
[19]. The method of any of paragraphs 1-18, which is carried out at pH 7-13, preferably pH 8-12, more preferably pH 9-1 1.
[20]. The method of any of paragraphs 1 -19, which is carried out in Britton-Robinson buffer, TRIS buffer or water.
[21]. A method for converting a substituted or unsubstituted indole to the corresponding 2,3- epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole, comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2, 3-epoxy-1 /-/-indole, or 3-hydroxy-1 /-/-indole is substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
[22]. A method for preparing a substituted or unsubstituted indigo dye, comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
[23]. The method of any of paragraphs 21-22, wherein each substituent is independently selected from the group consisting of CI, Br, OH, NH2, COOH, and SO3".
[24]. The method of paragraph 23, wherein each substituent is independently selected from the group consisting of CI, Br, OH, NH2, and SO3".
[25]. The method of any of paragraphs 21 -24, wherein the substituted or unsubstituted indole is the indole or indole substituted with Br.
[26]. The method of any of paragraph 21-25, comprising:
(a) contacting the textile with a peroxygenase, and a substituted or unsubstituted indole; and
(b) adding a source of hydrogen peroxide in one or more dosages.
[27]. The method of any of paragraphs 21 -25, comprising:
(a) contacting the textile with a source of hydrogen peroxide, and a substituted or unsubstituted indole; and
(b) adding a peroxygenase.
[28]. The method of any of paragraphs 21 -27, wherein the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, further more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, or 18, 19 or 20.
[29]. The method of any of paragraphs 21 -28, wherein the peroxygenase comprises or consists of an amino acid sequence having at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the amino acid sequence of SEQ ID NO: 1 , the amino acid sequence of SEQ ID NO: 2, the mature polypeptide of SEQ ID NO: 19 or the mature polypeptide of SEQ ID NO: 20.
[30]. The method of any of paragraphs 21-29, wherein the amino acid sequence of the peroxygenase comprises the motif: E-H-D-[G,A]-S-[L,I]-S-R (SEQ ID NO: 21 ).
[31]. The method of any of paragraphs 21 -30, wherein the peroxygenase comprises or consists of the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20; or a fragment thereof having peroxygenase activity.
[32]. The method of any of paragraphs 21-31 , wherein the peroxygenase is a peroxygenase variant, comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g. , at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[33]. The method of paragraph 32, wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[34]. The method of paragraph 32 or 33, wherein the variant is a variant of a parent peroxygenase, and wherein the parent peroxygenase has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[35]. The method of any of paragraphs 32-34, wherein the variant comprises one or more substitutions selected from the group consisting of
W5F
E6K,C
K1 1 N,C
M19L,G
H26N,Q,A
F28Y,L,V
R34K
K39Q
G44A
N52Q
T54A
A55L,V,F,I
A58L,V,F,S,I
L59I
F62V,L,A,G
M65T,L
N71 Q
N78D
H83N I85F,L,V
L86F
N106Q
K107C
T108A
W117F
S120G
F147T
M148L
L151 G,F,A,V
G152A.Q
N153D
I154V,T,A
F155I.V
T156C
G158A,T,F,L
E159D
A162F,L,I,V
Y163D.L
M165I.L
L166V
I167L
W179F
W183I.V.F
F184I.V.L
W195F
K200E
E201 S
V206H
A209T
Q215R, and
N216Q.
[36]. The method of any of paragraphs 32-35, wherein the variant comprises one or more substitutions selected from the group consisting of
A55L
N71 Q
1154V W183I
W183V
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+S120G+F147T+N153D+M165I+L1 66V+1167L+K200E+E201 S+V206H+A209T+Q215R
G158A+W183V
G158A+W183I
L151A+G158A
L151A+W183V
K107C+T108A
I85V+M165L
M165L+W179F
W117F+W195F
E6C+W1 17F; and
L151A+W183I.
[37]. The method of any paragraphs 21-36, which is flushed with nitrogen; preferably a source of hydrogen peroxide and the substituted or unsubstituted indole are mixed and flushed with nitrogen.
[38]. The method of any of paragraphs 21 -37, which is carried out under normal atmospheric conditions.
[39]. The method of any of paragraphs 21-38, which is carried out at pH 7-13, preferably pH
8-12, more preferably pH 9-1 1.
[40]. The method of any of paragraphs 21 -39, which is carried out in Britton-Robinson buffer, TRIS buffer, or water.
[41]. Use of a peroxygenase, a source of hydrogen peroxide, and an indole for in situ dyeing of a textile, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03-, alkyl and alkoxy.
[42]. Use of a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole for preparing an indigo dye, 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole, which is unsubstituted or substituted once or twice in the benzene ring(s), and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, SO3", alkyl and alkoxy.
[43]. The use according to paragraph 41 or 42, wherein each substituent is independently selected from the group consisting of CI, Br, OH, NH2, and SO3".
[44]. A peroxygenase variant, comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[45]. The peroxygenase variant of paragraph 44, wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[46]. The peroxygenase variant of paragraph 44 or 45, which is a variant of a parent peroxygenase, and wherein the parent peroxygenase has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
[47]. The peroxygenase variant of any of paragraphs 44-46, wherein the variant comprises one or more substitutions selected from the group consisting of
W5F
E6K,C
K1 1 N.C
M19L,G
H26N,Q,A
F28Y,L,V
R34K
K39Q
G44A
N52Q
T54A
A55L,V,F,I
A58L,V,F,S,I
L59I
F62V,L,A,G
M65T,L
N71 Q
N78D
H83N I85F,L,V
L86F
N 106Q
K107C
T108A
W1 17F
S120G
F147T
M148L
L151 G,F,A,V
G152A.Q
N 153D
I 154V,T,A
F155I.V
T156C
G158A,T,F,L
E159D
A162F,L,I,V
Y163D.L
M165I.L
L166V
I 167L
W179F
W183I.V.F
F184I.V.L
W195F
K200E
E201 S
V206H
A209T
Q215R, and
N216Q.
[48]. The peroxygenase variant of any of paragraphs 44-47, wherein the variant comprises one or more substitutions selected from the group consisting of
A55L
N71 Q
1154V W183I
W183V
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+S120G+F147T+N153D+M16 5I+L166V+1167L+K200E+E201 S+V206H+A209T+Q215R
G158A+W183V
G158A+W183I
L151A+G158A
L151A+W183V
K107C+T108A
I85V+M165L
M165L+W179F
W117F+W195F
E6C+W1 17F; and
L151A+W183I.
[49]. The peroxygenase variant of any of paragraphs 44-48, wherein the number of alterations is 1 -20, e.g., 1-10 and 1 -5, such as 1 , 2, 3, 4, 5, 6, 7, 8, 9 or 10 alterations.
The present invention is further described by the following examples that should not be construed as limiting the scope of the invention.
EXAMPLES
LC-DAD-MS Method for the Analysis of Indole and Reaction Products
Equipment:
MicroDegasser G1379B
Binary pump G1312B
High Performance AutoSampler (HiP ALS) G1367E
Thermostatted Column Compartment (TCC) G1316C
Detector 1 : Diode Array detector (DAD) G4212B
Detector 2: Single Quadrupole Mass detector (MS) G6120B
Vacuum pump (VARIAN MS40+) 949-9241
Nitrogen generator (PEAK) NM32LA
Column Luna C18 250x2 mm 5 μιη particle
Method:
Time (min) MilliQ+0.1 % Formic acid Acetonitril+0.1 % Formic acid Flow (mL/min)
0 80 % 20 % 0.35
10 20 % 80 % 0.35
15 5 % 95 % 0.35 Column was heated to 40 °C.
10 μΙ_ Reaction Medium was injected after centrifuging (10 min, 10000 g). If needed dilutions were prepared. Analysis of compounds was done via standards and mass spectrum.
MS-Detector Settings:
Gas Temp: 350 °C
DryingGas: 12.0 L/min
Neb Pres: 35 psig
Scan: 40.00 - 280.00 m/z
Fragmentor: 70 V / 180 V
Chemicals used as buffers and substrates were commercial products of at least reagent grade.
Humicola insolens unspecific peroxygenase (HinUPO): disclosed as mature polypeptide of SEQ ID NO:2 in WO 2013/021061 , and as SEQ ID NO: 19 herein;
Daldinia caldariorum unspecific peroxygenase (DcaUPO) disclosed as mature polypeptide of SEQ ID NO:2 in WO 2014/056917, and as SEQ ID NO: 20 herein;
Agrocybe aegerita unspecific peroxygenase (AaeUPO) disclosed as mature polypeptide of SEQ ID NO: 1 in WO 2014/122109, and as SEQ ID NO: 1 herein;
Coprinopsis cinerea unspecific peroxygenase (Cc/'UPO) disclosed as mature polypeptide of SEQ ID NO:2 in WO 2014/122109, and as SEQ ID NO: 2 herein.
Example 1 : Improved conversion and selectivity for an enzymatic conversion of indole to indigo using Humicola insolens unspecific peroxygenase (HinUPO) and Daldinia caldariorum unspecific peroxygenase (DcaUPO)
1 mM substrate (indole) was converted by 0.01 mg/mL peroxygenase in 1 ml. of 50 mM phosphate buffer and 1 mM Hydrogen peroxide.
A yellow color formation turning green and finally blue was observed shortly after reaction start indicating the formation of indigo dye. This is further supported by precipitation of blue dye and a turbid blue solution.
Table 1 : Results from LC-DAD-MS measurement. Substrate and major by-product concentrations after reaction are listed:
Figure imgf000030_0001
From the results, it can be seen that H/'nUPO and DcaUPO increase the conversion of indole, and the selectivity towards the by-product 2-Oxindole is decreased using H/'nUPO and DcaUPO compared to enzymes /AaeUPO and Cc/'UPO. Example 2: Increased yield of indigo using nitrogen atmosphere
5.725 mM substrate (indole) were converted by 0.01 mg/mL Humicola insolens unspecific peroxygenase (HinUPO) and variants thereof in 10 mL of 10 mM Britton-Robinson (BR, composed of phosphoric acid, acetic acid, boric acid, titrated with NaOH) buffer at different atmospheric conditions ( ) and 2 mM Hydrogen peroxide for 2 hours at room temperature.
For the reaction in nitrogen atmosphere, prior to enzyme addition, the substrate, buffer, hydrogen peroxide mixture was flushed with nitrogen for 15 minutes. The reaction was started with the addition of enzyme and nitrogen was bubbled trough the reaction over the course of the reaction. The product was stirred open after reaction for 1 hour.
The reaction under normal atmospheric conditions was conducted in a closed vessel during the reaction and after reaction stirred open for 1 hour.
The reaction with aeration was conducted under constant air bubbling. The products were stirred open after reaction for 1 hour.
A yellow color formation turning green and finally blue was observed shortly after reaction start indicating the formation of indigo dye. This is further supported by precipitation of blue dye and a turbid blue solution.
Quantification was performed using High Performance Liquid Chromatography (HPLC), diethylether extraction and sulfonation of the indigo. Thereby, formation of 2-Oxindole, unknown products and indigo was found.
From the results, it can be seen that H/'nUPO and the variants thereof could convert indole to an indigo dye in high yield at nitrogen atmosphere, and the variant with A55L mutation worked better than the other tested enzymes. The best results in terms of obtained indigo production were received for variant with A55L mutation under normal atmospheric conditions.
Table 2: Production indigo for the wild type H/'nUPO enzyme and variants thereof
Indigo Yield on Limiting Substrate
H/nUPO and Aeration
N2 Normal atmospheric conditions
variants
Wild type 61 .9 % 24.4 % 10.0 %
A55L 49.0 % 65.7 % 42.3 %
N71 Q 43.7 % 17.5 % 16.0 %
1154V 33.7 % 17.9 % 1 1 .5 %
W183I 47.1 % 24.7 % 18.4 % W183V 43.6 % 23.1 % 19.6 %
Percentages are given on the limiting substrate. Percentages were calculated the following way: [lndigo]*2/[H2O2]*100 (Concentration of indigo times 2 divided by the concentration of hydrogen peroxide (limiting substrate in this case) times 100) Example 3: Conversion of indole to indigo by peroxygenases at alkaline pH
5.725 mM substrate (indole) were converted by 0.01 mg/mL H/'nUPO in 10 mL of 5 mM
Britton-Robinson buffer at various pH (Table 3) and 2 mM Hydrogen peroxide. Prior to enzyme addition, the substrate, buffer, hydrogen peroxide mixture was flushed with nitrogen for 15 minutes. The reaction was started with the addition of enzyme.
A yellow color formation turning green and finally blue was observed shortly after reaction start indicating the formation of indigo dye. This is further supported by precipitation of blue dye and a turbid blue solution.
Quantification was performed using HPLC and sulfonation of the indigo. Thereby, formation of 2-Oxindole, unknown products and indirubin was found.
From the results, it can be seen that the reaction has a broad pH optimum reaching far into the alkaline region, and thereby, giving robustness to the reaction and the opportunity to adjust the system.
Table 3: Enzymatic Indigo production at elevated pH
Figure imgf000032_0001
Figure imgf000033_0001
Example 4: Improved conversion at pH=10 in TRIS (Tris(hydroxymethyl)aminomethane) buffer
5.725 mM substrate (indole) were converted by 0.01 mg/mL H/'nUPO in 10 mL of 5 mM TRIS buffer at various pH (Table 4) and 2 mM Hydrogen peroxide. Prior to enzyme addition, the substrate, buffer, hydrogen peroxide mixture was flushed with nitrogen for 15 minutes. The reaction was started with the addition of enzyme.
A yellow color formation turning green and finally blue was observed shortly after reaction start indicating the formation of indigo dye. This is further supported by precipitation of blue dye and a turbid blue solution.
Quantification was performed using HPLC and sulfonation of the indigo. Thereby, formation of 2-Oxindole, unknown products and indirubin was found.
From the results, it can be seen that the reaction at pH 10 with TRIS buffer resulted in the highest conversion to indigo. This is unnatural for this enzyme and it is surprising to find the enzyme can work at such alkaline pH.
Table 4: Improved conversion of indole to indigo with TRIS buffer at pH 10
Figure imgf000033_0002
Example 5: Screening of Humicola insolens unspecific peroxygenase variants
5.0/1.0 mM indole (Table 5) were converted by 0.01 mg/mL H/'nUPO and variants thereof indicated with different numbers in 96-well plate format with total reaction volume of 160 μΙ_. Reaction conditions were 5 mM TRIS pH=10 buffer, 2 mM H2O2, room temperature and shaking with 400 rpm on a plate shaker. The reaction was started with the addition of H2O2.
A yellow color formation turning green and finally blue was observed shortly after reaction start indicating the formation of indigo dye. This is further supported by precipitation of blue dye and a turbid blue solution.
Reaction was stopped using 10 μΙ_ of a 1 :10 dilution of Terminox Supreme (Novozymes A/S) and shaking for 30 min. Subsequently, 1 10 μΙ_ 96 % H2SO4 were added and absorbance at 640 nm was measured immediately.
Quantification was performed by the use of an indigo standard curve.
From the results, it can be seen that the reaction of indole to indigo could be catalyzed by a wide range of variants of H/'nUPO. Best picks are chosen to be validated via Liquid chromatography-mass spectrometry (LC-MS).
Table 5: Results from H/nUPO variants screening on indole at two different substrate concentrations
Figure imgf000034_0001
W183V 1 .0 0.187 ± 0.004
F28Y 5.0 0.073 ± 0.003
F28Y 1 .0 0.105 ± 0.005
F28L 5.0 0.073 ± 0.005
F28L 1 .0 0.108 ± 0.008
I85L 5.0 0.012 ± 0.001
I85L 1 .0 0.023 ± 0.000
I85V 5.0 0.040 ± 0.003
I85V 1 .0 0.076 ± 0.012
L151V 5.0 0.015 ± 0.001
L151V 1 .0 0.033 ± 0.003
W183F 5.0 0.037 ± 0.01 1
W183F 1 .0 0.005 ± 0.000
M19L 5.0 0.048 ± 0.010
M19L 1 .0 0.005 ± 0.000
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+ 5.0 0.003 ± 0.000 S120G+F147T+N153D+M165I+L166V+I167L+K200E+
E201 S+V206H+A209T+Q215R
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+ 1 .0 0.005 ± 0.001 S120G+F147T+N153D+M165I+L166V+I167L+K200E+
E201 S+V206H+A209T+Q215R
E6C 5.0 0.039 ± 0.027
E6C 1 .0 0.006 ± 0.001
I154A 5.0 0.048 ± 0.01 1
I154A 1 .0 0.017 ± 0.008
1154V 5.0 0.015 ± 0.001
1154V 1 .0 0.004 ± 0.001
F62V 5.0 0.007 ± 0.000
F62V 1 .0 0.004 ± 0.001
A55V 5.0 0.021 ± 0.007
A55V 1 .0 0.005 ± 0.000
G158A+W183V 5.0 0.005 ± 0.000
G158A+W183V 1 .0 0.003 ± 0.000
G158A+W183I 5.0 0.005 ± 0.001
G158A+W183I 1 .0 0.003 ± 0.000
L151A+G158A 5.0 0.003 ± 0.000
L151A+G158A 1 .0 0.003 ± 0.001
L151A+W183V 5.0 0.003 ± 0.000
L151A+W183V 1 .0 0.003 ± 0.000
H83N 5.0 0.021 ± 0.002 H83N 1.0 0.014 + 0.001
G152A 5.0 0.021 + 0.001
G152A 1.0 0.013 + 0.000
G152Q 5.0 0.022 + 0.005
G152Q 1.0 0.018 + 0.002
T156C 5.0 0.019 + 0.001
T156C 1.0 0.010 + 0.004
L86F 5.0 0.035 + 0.003
L86F 1.0 0.019 + 0.000
A55V 5.0 0.005 + 0.000
A55V 1.0 0.003 + 0.000
F62L 5.0 0.103 + 0.002
F62L 1.0 0.116 + 0.003
F62A 5.0 0.095 + 0.006
F62A 1.0 0.143 + 0.006
A58L 5.0 0.074 + 0.010
A58L 1.0 0.102 + 0.001
A58V 5.0 0.068 + 0.002
A58V 1.0 0.105 + 0.004
W117F 5.0 0.031 + 0.001
W117F 1.0 0.065 + 0.004
W195F 5.0 0.046 + 0.002
W195F 1.0 0.109 + 0.005
N106Q 5.0 0.059 + 0.001
N106Q 1.0 0.125 + 0.011
E159D 5.0 0.007 + 0.002
E159D 1.0 0.010 + 0.002
A162I 5.0 0.110 + 0.005
A162I 1.0 0.119 + 0.014
A162V 5.0 0.050 + 0.005
A162V 1.0 0.090 + 0.013
F184I 5.0 0.045 + 0.003
F184I 1.0 0.082 + 0.003
F184V 5.0 0.025 + 0.004
F184V 1.0 0.050 + 0.005
F28V 5.0 0.086 + 0.012
F28V 1.0 0.118 + 0.005
M65L 5.0 0.076 + 0.007
M65L 1.0 0.113 + 0.008 N52Q 5.0 0.057 + 0.003
N52Q 1.0 0.111 + 0.009
T73A 5.0 0.075 + 0.014
T73A 1.0 0.118 + 0.019
G158T 5.0 0.017 + 0.001
G158T 1.0 0.021 + 0.001
L151A 5.0 0.015 + 0.002
L151A 1.0 0.019 + 0.001
F184L 5.0 0.016 + 0.001
F184L 1.0 0.020 + 0.002
F62G 5.0 0.017 + 0.002
F62G 1.0 0.020 + 0.002
K11C 5.0 0.055 + 0.025
K11C 1.0 0.004 + 0.000
K107C+T108A 5.0 0.130 + 0.035
K107C+T108A 1.0 0.005 + 0.000
N216Q 5.0 0.024 + 0.010
N216Q 1.0 0.006 + 0.001
G158F 5.0 0.008 + 0.001
G158F 1.0 0.006 + 0.001
I85V+M165L 5.0 0.018 + 0.007
I85V+M165L 1.0 0.005 + 0.001
M165L+W179F 5.0 0.011 + 0.004
M165L+W179F 1.0 0.004 + 0.001
W117F+W195F 5.0 0.008 + 0.003
W117F+W195F 1.0 0.006 + 0.003
E6C+W117F 5.0 0.004 + 0.001
E6C+W117F 1.0 0.005 + 0.001
L151A+W183I 5.0 0.008 + 0.002
L151A+W183I 1.0 0.004 + 0.000
H26N 5.0 0.005 + 0.001
H26N 1.0 0.003 + 0.000
H26Q 5.0 0.018 + 0.004
H26Q 1.0 0.004 + 0.001
H26A 5.0 0.008 + 0.001
H26A 1.0 0.007 + 0.004
M19G 5.0 0.019 + 0.003
M19G 1.0 0.062 + 0.004
Y163D 5.0 0.006 + 0.000 Y163D 1 .0 0.048 + 0.003
Y163L 5.0 0.031 + 0.007
Y163L 1 .0 0.087 + 0.007
L59I 5.0 0.008 + 0.002
L59I 1 .0 0.020 + 0.002
A58I 5.0 0.007 + 0.000
A58I 1 .0 0.005 + 0.000
A55F 5.0 0.009 + 0.000
A55F 1 .0 0.010 + 0.001
A55I 5.0 0.193 + 0.004
A55I 1 .0 0.128 + 0.010
M148L 5.0 0.050 + 0.000
M148L 1 .0 0.070 + 0.003
M165L 5.0 0.195 + 0.007
M165L 1 .0 0.157 + 0.006
G158A 5.0 0.020 + 0.001
G158A 1 .0 0.064 + 0.003
G158L 5.0 0.051 + 0.003
G158L 1 .0 0.063 + 0.004
F155I 5.0 0.009 + 0.002
F155I 1 .0 0.01 1 + 0.000
F155V 5.0 0.006 + 0.001
F155V 1 .0 0.008 + 0.000
Standard error is given of 3 technical replica
Example 6: Upscaling of reaction to 100 ml_
5.725 mM indole were converted by 0.01 mg/mL H/'nUPO in 100 mL of 5 mM TRIS buffer at pH 10 and 2 mM Hydrogen peroxide. Prior to enzyme addition, the substrate, buffer, hydrogen peroxide mixture was flushed with nitrogen for 15 minutes. The reaction was started with the addition of enzyme via a syringe.
A yellow color formation turning green and finally blue was observed shortly after reaction start indicating the formation of indigo dye. This is further supported by precipitation of blue dye and a turbid blue solution.
Quantification was performed using HPLC and sulfonation of the indigo. Thereby, formation of 2-Oxindole and unknown products was found (Table 6).
Surprisingly, higher yields were obtained when increasing the scale of the reaction. It can also be seen that the reaction worked well at larger scale.
Table 6: Yields of upscale experiment. Percentages are given based on limiting substrate: Product Quantity
Indigo 72.4 %
2-Oxindole 21.8 %
Unknown products 5.80 %
Example 7: Improved conversion and selectivity for the enzymatic conversion of 6- bromoindole to Tyrian purple using Humicola insolens unspecific peroxygenase (H/nllPO)
Typical reaction mixtures (1.0 ml) contained purified H/'nUPO (0.1 mg/mL and 0.3 mg/mL), substrate to be oxidized (6-bromoindole; 0.5-2.0 mM; stock solution 50/50 H2O/ACN = 5% end concentration), potassium phosphate buffer (50 mM, pH 7.0) and water. The reactions were started by the addition of limiting H2O2 (2.0-5.0 mM) and stirred at room temperature over half an hour. Rest product and 6-Br-2-oxindole were obtained, by use of HPLC, 6,6'-dibromoindigo by sulfonation. By the conversion with 0.1 mg/mL H/'nUPO, about 60% of substrate was converted to 6,6'-dibromoindigo, 30% to 6-Br-2-oxindole. Rest was converted to other, unknown polymers. By the conversion with higher concentration of H/'nUPO, the yield of 6,6'-dibromoindigo has no significant changed, and the 6-Br-2-oxindole was converted to other polymers.
Example 8: In situ dyeing process based on the conversion of 6-bromoindole to Tyrian purple catalyzed by Coprinopsis cinerea unspecific peroxygenase (Cc/UPO)
5 Liter of 100 mM potassium phosphate buffer (pH 7) was filled into a 25 liter steel tank. 2 g of substrate (6-bromoindole) was dissolved in the mixture of 250 mL water and 250 mL acetonitrile. The substrate solution was added to the buffer. The reaction volume was filled with water to the end volume of 10 Liter (subtracted volume of enzyme solution and hydrogen peroxide). The shaker was turn on with the speed of 150 to 180 rpm. After 5 minutes shaking 100g cotton fabric was put into the mixture. After that 9 mg Cc/UPO dissolved in 500mL water was added (end concentration of enzyme 0.9 μg/mL). The reaction was started with addition of first portion of hydrogen peroxide (250 mL; 1.25 mM). Hydrogen peroxide was added as 1 L of 50 mM solution in four portion, 250 mL every 30 minutes. After 2 hours, the cotton fabric was removed from the reactor, washed under running water and air-dried.
The originally white fabric turns its color to purple (color intermediate between red and blue); the color is identical to that of Tyrian purple (also known as imperial purple), a natural dye that is prepared from sea snails of the family Muricidae. Example 9: In situ dyeing process based on the conversion of 6-bromoindole to Tyrian purple catalyzed by Agrocybe aegerita peroxygenase
6-bromoindole (1 mM, dissolved in 50/50 v/v acetonitrile/water (ACN/H2O), ACN final concentration was reduced to 2.5%) was converted by 0.025 μg/mL Agrocybe aegerita peroxygenase (/AaeUPO) in 5 L of 50 mM potassium phosphate buffer (pH 7). Total reaction volume was 10 Liter. The same reactor was used as in example 8 (steel tank with a volume of 25 L). The reactor was placed on a laboratory shaker. Prior to hydrogen peroxide addition that initiated the dyeing reaction, about 200 g cotton fabric (two white T-shirts) were added to the reaction mixture. The reaction was started by the addition of a first portion of hydrogen peroxide (1 .25 mM, then continued to 5 mM H2O2 final concentration added in four portion every half an hour). The reactor was shaken with a rotation speed of 180 rpm. After 2 hours, the cotton fabric was removed from the reactor, washed under running water and air-dried. The originally white fabric turns its color to purple (color intermediate between red and blue); the color is identical to that of Tyrian purple (also known as imperial purple), a natural dye that is prepared from sea snails of the family Muricidae. The experimental process was analogous to example 8.

Claims

1. A method for dyeing a textile, comprising: contacting the textile with a peroxygenase, a source of hydrogen peroxide, and an indole, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
2. The method of claim 1 , wherein the peroxygenase has an increased selectivity for 3-hydroxy- 1 /-/-indole; preferably the peroxygenase has at least 1 10%, for example, at least 150%, at least 200%, at least 300%, at least 500%, at least 800%, or at least 1000% selectivity for 3-hydroxy- 1 /-/-indole, compared with Agrocybe aegerita unspecific peroxygenase, when the peroxygenase is used to convert the indole to an indigo dye.
3. The method of claim 1 or 2, wherein the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, further more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, or 18, 19 or 20.
4. The method of any of claims 1-3, wherein the peroxygenase is a peroxygenase variant, comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
5. The method of claim 4, wherein the variant comprises one or more substitutions selected from the group consisting of
W5F
E6K,C
K1 1 N,C
M19L,G H26N,Q,A
F28Y,L,V
R34K
K39Q
G44A
N52Q
T54A
A55L,V,F,I
A58L,V,F,S,I
L59I
F62V,L,A,G
M65T.L
N71 Q
N78D
H83N
I85F,L,V
L86F
N106Q
K107C
T108A
W117F
S120G
F147T
M148L
L151 G,F,A,V
G152A.Q
N153D
I154V,T,A
F155I.V
T156C
G158A,T,F,L
E159D
A162F,L,I,V
Y163D.L
M165I.L
L166V
I167L W179F
W183I.V.F
F184I.V.L
W195F
K200E
E201 S
V206H
A209T
Q215R, and
N216Q.
6. The method of any of claims 4-5, wherein the variant comprises one or more substitutions selected from the group consisting of
A55L
N71 Q
1154V
W183I
W183V
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+S120G+F147T+N153D+M16 5I+L166V+I167L+K200E+E201 S+V206H+A209T+Q215R
G158A+W183V
G158A+W183I
L151A+G158A
L151A+W183V
K107C+T108A
I85V+M165L
M165L+W179F
W117F+W195F
E6C+W1 17F; and
L151A+W183I.
7. A method for converting a substituted or unsubstituted indole to the corresponding 2,3-epoxy- 1 /-/-indole or 3-hydroxy-1 /-/-indole, comprising contacting the indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole, 2, 3-epoxy-1 /-/-indole, or 3-hydroxy-1 /-/-indole is substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
8. A method for preparing a substituted or unsubstituted indigo dye, comprising contacting an indole with a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole, and a source of hydrogen peroxide; wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
9. The method of claim 7 or 8, wherein the peroxygenase comprises or consists of an amino acid sequence which has at least 70% identity, e.g., at least 75% identity, or at least 80% identity, preferably at least 85% identity, more preferably at least 90% identity, further more preferably at least 95% identity, most preferably at least 97% identity, and in particular at least 99% identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, or 18, 19 or 20. 10. The method of any of claims 7-9, wherein the peroxygenase is a peroxygenase variant, comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9,
10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
1 1. The method of claims 10, wherein the variant comprises one or more substitutions selected from the group consisting of
W5F
E6K,C
K1 1 N,C
M19L,G
H26N,Q,A
F28Y,L,V
R34K
K39Q
G44A
N52Q T54A A55L,V,F,I A58L,V,F,S,I L59I
F62V,L,A,G
M65T.L
N71 Q
N78D
H83N
I85F,L,V
L86F
N106Q
K107C
T108A
W117F
S120G
F147T
M148L
L151 G,F,A,V
G152A.Q
N153D
I154V,T,A
F155I.V
T156C
G158A,T,F,L
E159D
A162F,L,I,V
Y163D.L
M165I.L
L166V
I167L
W179F
W183I,V,F
F184I.V.L
W195F
K200E
E201 S V206H
A209T
Q215R, and
N216Q.
12. The method of claim 10 or 11 , wherein the variant comprises one or more substitutions selected from the group consisting of
A55L
N71 Q
1154V
W183I
W183V
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+S120G+F147T+N153D+M165I+ L166V+1167L+K200E+E201 S+V206H+A209T+Q215R
G158A+W183V
G158A+W183I
L151A+G158A
L151A+W183V
K107C+T108A
I85V+M165L
M165L+W179F
W117F+W195F
E6C+W1 17F; and
L151A+W183I.
13. Use of a peroxygenase, a source of hydrogen peroxide, and an indole for in situ dyeing of a textile, wherein the indole is unsubstituted or substituted once or twice in the benzene ring and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
14. Use of a peroxygenase having an increased selectivity for 3-hydroxy-1 /-/-indole for preparing an indigo dye, 2, 3-epoxy-1 /-/-indole or 3-hydroxy-1 /-/-indole, which is unsubstituted or substituted once or twice in the benzene ring(s), and wherein each substituent is independently selected from the group consisting of F, CI, Br, OH, NH2, COOH, S03 ", alkyl and alkoxy.
15. A peroxygenase variant, comprising an alteration at one or more positions corresponding to positions 5, 6, 1 1 , 19, 26, 28, 34, 39, 44, 52, 54, 55, 58, 59, 62, 65, 71 , 78, 83, 85, 86, 106, 107, 1 17, 120, 147, 151 , 152, 154, 156, 158, 162, 163, 165, 166, 167, 179, 183, 184, 195, 200, 201 , 206, 209, 215 and 216 of the mature polypeptide of SEQ ID NO: 19, wherein each alteration is independently a substitution, deletion or insertion and the variant has peroxygenase activity and wherein the variant has at least 70%, e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to the mature polypeptide of SEQ ID NO: 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, preferably the mature polypeptide of SEQ ID NO: 1 , 2, 19 or 20.
16. The peroxygenase variant of claims 15, wherein the variant comprises one or more substitutions selected from the group consisting of
W5F
E6K,C
K1 1 N,C
M19L,G
H26N,Q,A
F28Y,L,V
R34K
K39Q
G44A
N52Q
T54A
A55L,V,F,I
A58L,V,F,S,I
L59I
F62V,L,A,G
M65T,L
N71 Q
N78D
H83N
I85F,L,V
L86F
N106Q
K107C
T108A
W117F
S120G
F147T L151 G,F,A,V
G152A.Q
N153D
I154V,T,A
F155I.V
T156C
G158A,T,F,L
E159D
A162F,L,I,V
Y163D.L
M165I.L
L166V
I167L
W179F
W183I.V.F
F184I.V.L
W195F
K200E
E201 S
V206H
A209T
Q215R, and
N216Q.
17. The peroxygenase variant of claim 15 or 16, wherein the variant comprises one or more substitutions selected from the group consisting of
A55L
N71 Q
1154V
W183I
W183V
E6K+K1 1 N+R34K+K39Q+G44A+A58S+M65T+N78D+S120G+F147T+N153D+M165I+L1 66V+1167L+K200E+E201 S+V206H+A209T+Q215R
G158A+W183V
G158A+W183I
L151A+G158A L151A+W183V K107C+T108A I85V+M165L M165L+W179F W117F+W195F E6C+W117F; and L151A+W183I.
PCT/EP2017/066410 2016-07-01 2017-07-03 Enzymatic preparation of indigo dyes and in situ dyeing process WO2018002379A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16177463.3 2016-07-01
EP16177463 2016-07-01

Publications (2)

Publication Number Publication Date
WO2018002379A2 true WO2018002379A2 (en) 2018-01-04
WO2018002379A3 WO2018002379A3 (en) 2018-02-08

Family

ID=56372758

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2017/066410 WO2018002379A2 (en) 2016-07-01 2017-07-03 Enzymatic preparation of indigo dyes and in situ dyeing process

Country Status (1)

Country Link
WO (1) WO2018002379A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020015839A1 (en) * 2018-07-20 2020-01-23 Sanko Tekstil Isletmeleri San. Ve Tic. A.S. Process and apparatus for dyeing textiles
WO2021013371A1 (en) * 2019-07-22 2021-01-28 Sanko Tekstil Isletmeleri San. Ve Tic. A.S. Process for dyeing textiles
CN113123144A (en) * 2020-01-14 2021-07-16 尚科纺织企业工业及贸易公司 Method for dyeing textiles and enzymes for use therein

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006204A1 (en) 1990-09-28 1992-04-16 Ixsys, Inc. Surface expression libraries of heteromeric receptors
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO1995017413A1 (en) 1993-12-21 1995-06-29 Evotec Biosystems Gmbh Process for the evolutive design and synthesis of functional polymers based on designer elements and codes
WO1995022625A1 (en) 1994-02-17 1995-08-24 Affymax Technologies N.V. Dna mutagenesis by random fragmentation and reassembly
WO1995029996A1 (en) 1994-05-03 1995-11-09 Novo Nordisk A/S Alkaline glucose oxidase
WO1999031990A1 (en) 1997-12-22 1999-07-01 Novo Nordisk A/S Carbohydrate oxidase and use thereof in baking
WO2000050606A1 (en) 1999-02-24 2000-08-31 Novozymes Biotech, Inc. Polypeptides having galactose oxidase activity and nucleic acids encoding same
US6248575B1 (en) 1998-05-18 2001-06-19 Novozymes Biotech, Inc. Nucleic acids encoding polypeptides having L-amino acid oxidase activity
US20040171154A1 (en) 2001-07-27 2004-09-02 Francesca Storici Systems for in vivo site-directed mutagenesis using oligonucleotides
WO2008051491A2 (en) 2006-10-20 2008-05-02 Danisco Us, Inc. Genencor Division Polyol oxidases
WO2013021061A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2014056917A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014122109A1 (en) 2013-02-05 2014-08-14 Novozymes A/S Enzymatic preparation of indigo dyes and intermediates

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO1992006204A1 (en) 1990-09-28 1992-04-16 Ixsys, Inc. Surface expression libraries of heteromeric receptors
WO1995017413A1 (en) 1993-12-21 1995-06-29 Evotec Biosystems Gmbh Process for the evolutive design and synthesis of functional polymers based on designer elements and codes
WO1995022625A1 (en) 1994-02-17 1995-08-24 Affymax Technologies N.V. Dna mutagenesis by random fragmentation and reassembly
WO1995029996A1 (en) 1994-05-03 1995-11-09 Novo Nordisk A/S Alkaline glucose oxidase
WO1999031990A1 (en) 1997-12-22 1999-07-01 Novo Nordisk A/S Carbohydrate oxidase and use thereof in baking
US6248575B1 (en) 1998-05-18 2001-06-19 Novozymes Biotech, Inc. Nucleic acids encoding polypeptides having L-amino acid oxidase activity
WO2000050606A1 (en) 1999-02-24 2000-08-31 Novozymes Biotech, Inc. Polypeptides having galactose oxidase activity and nucleic acids encoding same
US20040171154A1 (en) 2001-07-27 2004-09-02 Francesca Storici Systems for in vivo site-directed mutagenesis using oligonucleotides
WO2008051491A2 (en) 2006-10-20 2008-05-02 Danisco Us, Inc. Genencor Division Polyol oxidases
WO2013021061A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2014056917A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014122109A1 (en) 2013-02-05 2014-08-14 Novozymes A/S Enzymatic preparation of indigo dyes and intermediates

Non-Patent Citations (40)

* Cited by examiner, † Cited by third party
Title
ATSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402
BARTON ET AL., NUCLEIC ACIDS RES., vol. 18, 1990, pages 7349 - 4966
BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156
CALISSANO; MACINO, FUNGAL GENET. NEWSLETT, vol. 43, 1996, pages 15 - 16
CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085
DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312
DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145
EDGAR, NUCLEIC ACIDS RESEARCH, vol. 32, 2004, pages 1792 - 1797
GOUGH ET AL., J. MOL. BIOL., vol. 313, 2000, pages 903 - 919
H. NEURATH; R.L. HILL: "The Proteins", 1979, ACADEMIC PRESS
HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708
HOLM; PARK, BIOINFORMATICS, vol. 16, 2000, pages 566 - 567
HOLM; SANDER, PROTEINS, vol. 33, 1998, pages 88 - 96
JONES, J. MOL. BIOL., vol. 287, 1999, pages 797 - 815
KATOH ET AL., METHODS IN MOLECULAR BIOLOGY, vol. 537, 2009, pages 39 - 64
KATOH ET AL., NUCLEIC ACIDS RESEARCH, vol. 33, 2005, pages 511 - 518
KATOH; KUMA, NUCLEIC ACIDS RESEARCH, vol. 30, 2002, pages 3059 - 3066
KATOH; TOH, BIOINFORMATICS, vol. 23, 2007, pages 372 - 374
KATOH; TOH, BIOINFORMATICS, vol. 26, 2010, pages 1899 - 1900
KREN ET AL., NAT. MED., vol. 4, 1998, pages 285 - 290
LINDAHL; ELOFSSON, J. MOL. BIOL., vol. 295, 2000, pages 613 - 615
LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837
LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10837
M. PORAJ-KOBIELSKA; M. KINNE; R. ULLRICH; K. SCHEIBNER; M. HOFRICHTER: "A spectrophotometric assay for the detection of fungal peroxygenases", ANALYTICAL BIOCHEMISTRY, vol. 421, no. 1, 2012, pages 327 - 329
MCGUFFIN; JONES, BIOINFORMATICS, vol. 19, 2003, pages 874 - 881
NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453
NER ET AL., DNA, vol. 7, 1988, pages 127
NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896
PASTA ET AL., BIOTECHNOLOGY & BIOENGINEERING, vol. 62, no. 4, 1999, pages 489 - 493
REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57
RICE ET AL.: "EMBOSS: The European Molecular Biology Open Software Suite", TRENDS GENET., vol. 16, 2000, pages 276 - 277
RICE ET AL.: "EMBOSS: The European Molecular Biology Open Software Suite", TRENDS IN GENETICS, vol. 16, 2000, pages 276 - 277, Retrieved from the Internet <URL:http://emboss.org>
SCHERER; DAVIS, PROC. NATL. ACAD. SCI. USA, vol. 76, 1979, pages 4949 - 4955
SHINDYALOV; BOURNE, PROTEIN ENGINEERING, vol. 11, 1998, pages 739 - 747
SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904
STORICI ET AL., NATURE BIOTECHNOL., vol. 19, 2001, pages 773 - 776
THOMPSON ET AL., NUCLEIC ACIDS RESEARCH, vol. 22, 1994, pages 4673 - 4680
TIAN ET AL., NATURE, vol. 432, 2004, pages 1050 - 1054
ULLRICH ET AL., APPL. ENV. MICROBIOL., vol. 70, no. 8, 2004, pages 4575 - 4581
WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020015839A1 (en) * 2018-07-20 2020-01-23 Sanko Tekstil Isletmeleri San. Ve Tic. A.S. Process and apparatus for dyeing textiles
WO2021013371A1 (en) * 2019-07-22 2021-01-28 Sanko Tekstil Isletmeleri San. Ve Tic. A.S. Process for dyeing textiles
CN114222841A (en) * 2019-07-22 2022-03-22 尚科纺织企业工业及贸易公司 Textile dyeing process
CN114222841B (en) * 2019-07-22 2024-04-12 尚科纺织企业工业及贸易公司 Textile dyeing process
CN113123144A (en) * 2020-01-14 2021-07-16 尚科纺织企业工业及贸易公司 Method for dyeing textiles and enzymes for use therein
EP3851574A1 (en) * 2020-01-14 2021-07-21 Sanko Tekstil Isletmeleri San. Ve Tic. A.S. Process for dyeing textiles and enzymes used therein
WO2021144356A1 (en) * 2020-01-14 2021-07-22 Sanko Tekstil Isletmeleri San. Ve Tic. A.S. Process for dyeing textiles and enzymes used therein
US11920290B2 (en) 2020-01-14 2024-03-05 Sanko Tekstil Isletmeleri San. Ve Tic A.S. Process for dyeing textiles and enzymes used therein

Also Published As

Publication number Publication date
WO2018002379A3 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
WO2018002379A2 (en) Enzymatic preparation of indigo dyes and in situ dyeing process
CN107267485A (en) Stabilized alpha-amylase variants and application thereof
US20150152452A1 (en) Enzymatic Oxidation of 5-Hydroxymethylfurfural and Derivatives Thereof
US9057040B2 (en) Laccase variants
CN109415421B (en) Alpha-amylase variants and polynucleotides encoding same
CN108603185A (en) Enzyme variants and the polynucleotides for encoding them
CN109825538B (en) Synthesis method of chiral 2-amino-1-butanol
CA3046670A1 (en) Alpha-amylase variants
US10982197B2 (en) P450-BM3 variants with improved activity
JP2014519834A (en) Polypeptide having protease activity and polynucleotide encoding the same
CA3159083A1 (en) Alpha-amylase variants
CN110662837B (en) Mannanase variants and polynucleotides encoding same
CA3160401A1 (en) Cleaning compositions comprising polypeptides having alpha amylase activity
JP6985295B2 (en) Mutant polypeptides with improved performance and their use
WO2014122109A1 (en) Enzymatic preparation of indigo dyes and intermediates
JP2013132226A (en) METHOD FOR PRODUCING (-)-3a,6,6,9a-TETRAMETHYLDODECAHYDRONAPHTHO [2,1-b] FURAN
US20110059503A1 (en) Compositions of variant biocatalysts for preparing enantiopure amino acids
EP2876156A1 (en) New enzymes and method for preparing hydroxylated L-lysine or L-ornithine and analogs thereof
JPH0670765A (en) Protease, gene coding the same, method for producing the protease and its use
Monroe Natural and Non-natural Reactivity of Heme-Thiolate Proteins

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17737754

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17737754

Country of ref document: EP

Kind code of ref document: A2